Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
APOA2,Apolipoprotein A-II,Lifestyle factors,X1050.Time spend outdoors in summer,47386,0.0372724513495044,0.0283934028990532,-0.0183786183326398,0.0929235210316486,0.189294973361243
APOA2,Apolipoprotein A-II,Lifestyle factors,X1060.Time spent outdoors in winter,45498,0.00421625594732728,0.031519036949361,-0.0575610564734202,0.0659935683680747,0.893587188247824
APOA2,Apolipoprotein A-II,Physical activities,X1070.Time spent watching television (TV),48120,0.0800146793256649,0.028082508338472,0.0249729629822599,0.13505639566907,0.00438653715743521
APOA2,Apolipoprotein A-II,Physical activities,X1080.Time spent using computer,45493,-0.119273480471926,0.0279395829084022,-0.174035062972395,-0.0645118979714577,1.97441455078259e-05
APOA2,Apolipoprotein A-II,Physical activities,X1090.Time spent driving,43178,-0.122620403570473,0.0305315117423988,-0.182462166585575,-0.0627786405553718,5.94426458225185e-05
APOA2,Apolipoprotein A-II,Lifestyle factors,X1160.Sleep duration,49040,-0.0377910050482551,0.0258089305107199,-0.0883765088492661,0.0127944987527558,0.143138085137362
APOA2,Apolipoprotein A-II,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34850,0.00284111143201951,0.0198395910835376,-0.0360444870917142,0.0417267099557532,0.88613358259796
APOA2,Apolipoprotein A-II,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34850,-0.0228810918868623,0.0220769278687134,-0.0661518705095406,0.0203896867358159,0.300043757369345
APOA2,Apolipoprotein A-II,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34850,0.00963454092548143,0.0234485390585334,-0.0363245956292439,0.0555936774802068,0.681174452037481
APOA2,Apolipoprotein A-II,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34850,0.0362690063030817,0.0243669472416116,-0.011490210290477,0.0840282228966404,0.13668245497637
APOA2,Apolipoprotein A-II,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34850,-0.0112232117113918,0.0246797538564044,-0.0595955292699445,0.0371491058471608,0.649302169178626
APOA2,Apolipoprotein A-II,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34850,-0.0165362280719401,0.066724840509051,-0.14731691546968,0.1142444593258,0.804276276880681
APOA2,Apolipoprotein A-II,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34850,0.0893471074788247,0.0787615134978347,-0.0650254589769314,0.243719673934581,0.256670057204801
APOA2,Apolipoprotein A-II,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34850,0.0315590675880389,0.0395248396882655,-0.0459096182009616,0.109027753377039,0.424632994318982
APOA2,Apolipoprotein A-II,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34850,0.0386819204336117,0.0305798648869554,-0.0212546147448209,0.0986184556120443,0.205937347319666
APOA2,Apolipoprotein A-II,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34850,-0.0268123633574064,0.0202354762221542,-0.0664738967528285,0.0128491700380158,0.185213732590857
APOA2,Apolipoprotein A-II,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34850,0.027518228285697,0.0322017070101437,-0.0355971174541846,0.0906335740255786,0.39282860788398
APOA2,Apolipoprotein A-II,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34850,0.00455515409110854,0.0151226694291674,-0.0250852779900596,0.0341955861722767,0.76326162043819
APOA2,Apolipoprotein A-II,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34850,-0.00134430731123279,0.0205049163557913,-0.0415339433685837,0.0388453287461181,0.947730038816347
APOA2,Apolipoprotein A-II,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34850,0.0263002267451209,0.0328980693195034,-0.0381799891211058,0.0907804426113476,0.424062283544236
APOA2,Apolipoprotein A-II,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34850,-0.0171634273462759,0.0301853307260335,-0.0763266755693014,0.0419998208767497,0.569646968027204
APOA2,Apolipoprotein A-II,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34850,0.00819982451111896,0.0370593357797975,-0.0644364736172842,0.0808361226395222,0.824895627484252
APOA2,Apolipoprotein A-II,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34850,-0.0119412293464694,0.0368009856315104,-0.0840711611842298,0.0601887024912911,0.745584584138727
APOA2,Apolipoprotein A-II,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34850,-0.0389409197085392,0.0230169066023947,-0.0840540566492329,0.00617221723215454,0.0907263633764217
APOA2,Apolipoprotein A-II,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34850,-0.0160231222343379,0.0226013823828099,-0.0603218317046454,0.0282755872359696,0.478385457299371
APOA2,Apolipoprotein A-II,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34850,0.0213373661117567,0.0251071255589225,-0.0278725999837313,0.0705473322072448,0.39543936886966
APOA2,Apolipoprotein A-II,Health and medical history,X120040.Fatigue severity over the past week,34858,-0.0735628422723506,0.0506417186919185,-0.172820610908511,0.0256949263638096,0.146381258753072
APOA2,Apolipoprotein A-II,Health and medical history,X120041.Waking unrefreshed severity over the past week,34861,-0.0648360763765646,0.0498003824452274,-0.16244482596921,0.0327726732160812,0.192991903471051
APOA2,Apolipoprotein A-II,Health and medical history,X120042.Cognitive symptoms severity over the past week,34860,-0.138389395739066,0.0549665238146967,-0.246123782415872,-0.0306550090622608,0.011837041856036
APOA2,Apolipoprotein A-II,Health and medical history,X120098.Mobility problems today,34862,0.0396783081669702,0.0578673731948497,-0.0737417432949352,0.153098359628876,0.492942412421692
APOA2,Apolipoprotein A-II,Health and medical history,X120099.Self-care problems today,34862,0.102149872403405,0.0865526918644402,-0.067493403650898,0.271793148457708,0.237963759429883
APOA2,Apolipoprotein A-II,Health and medical history,X120100.Problems doing usual activities,34862,0.0695466497995873,0.0559592510214798,-0.0401334822025131,0.179226781801688,0.213984853737637
APOA2,Apolipoprotein A-II,Health and medical history,X120101.Pain or discomfort today,34862,0.116051355251652,0.0500701460768635,0.0179138689409998,0.214188841562305,0.0204936130161581
APOA2,Apolipoprotein A-II,Health and medical history,X120102.Anxiety or depression today,34862,-0.0167687431219952,0.063872275804809,-0.141958403699421,0.10842091745543,0.792917220944178
APOA2,Apolipoprotein A-II,Health and medical history,X120103.Scale to indicate how health is today,34848,0.000912735775972573,0.00655412759994658,-0.0119333543199227,0.0137588258718679,0.889248225140328
APOA2,Apolipoprotein A-II,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34847,-0.0320575355912358,0.0627972265754226,-0.155140099679064,0.0910250284965925,0.60972426104053
APOA2,Apolipoprotein A-II,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34845,0.055464880025322,0.0665971198523582,-0.0750654748853001,0.185995234935944,0.40496569010079
APOA2,Apolipoprotein A-II,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34851,-0.0227565498689615,0.0508650696880214,-0.122452086457483,0.0769389867195603,0.654608627692529
APOA2,Apolipoprotein A-II,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34856,-0.0888545846322498,0.0516682830770771,-0.190124419463321,0.0124152501988214,0.0855342173649147
APOA2,Apolipoprotein A-II,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34855,-0.0628092625836721,0.073723671205883,-0.207307658147203,0.0816891329798585,0.394271603299806
APOA2,Apolipoprotein A-II,Health and medical history,X120109.Feeling bad about self over the last two weeks,34843,-0.0207641686414782,0.0703491270806103,-0.158648457719474,0.117120120436518,0.767882340507108
APOA2,Apolipoprotein A-II,Health and medical history,X120110.Trouble concentrating over the last two weeks,34859,-0.0485958119382338,0.0672456196830823,-0.180397226517075,0.0832056026406074,0.469914960977192
APOA2,Apolipoprotein A-II,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34854,-0.0502371491777088,0.0991270928475857,-0.244526251158977,0.144051952803559,0.612316295901468
APOA2,Apolipoprotein A-II,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34821,0.147542590347711,0.136364903482279,-0.119732620477555,0.414817801172977,0.279308279648882
APOA2,Apolipoprotein A-II,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",32479,0.0853070813595678,0.070508087544329,-0.052888770227317,0.223502932946453,0.226394589542886
APOA2,Apolipoprotein A-II,Lifestyle factors,X1269.Exposure to tobacco smoke at home,46809,0.0320718630714921,0.061041938341237,-0.0875703360773323,0.151714062220317,0.599306670611444
APOA2,Apolipoprotein A-II,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,45750,0.0154015555228826,0.0357617192311913,-0.0546914141702524,0.0854945252160175,0.66671261098118
APOA2,Apolipoprotein A-II,Diet and food preferences,X1289.Cooked vegetable intake,48218,-0.0901139943750197,0.0269438692150282,-0.142923978036475,-0.0373040107135645,0.000825829898520513
APOA2,Apolipoprotein A-II,Diet and food preferences,X1299.Salad  or  raw vegetable intake,47496,-0.0116207843410799,0.0277434666935029,-0.0659979790603455,0.0427564103781857,0.675319106391998
APOA2,Apolipoprotein A-II,Diet and food preferences,X1309.Fresh fruit intake,48109,-0.0505923916186485,0.028404017858917,-0.106264266622126,0.0050794833848288,0.0749001967616346
APOA2,Apolipoprotein A-II,Diet and food preferences,X1319.Dried fruit intake,47236,-0.0347170733924897,0.0301852737770982,-0.0938802099956023,0.0244460632106228,0.250103938697754
APOA2,Apolipoprotein A-II,Health and medical history,X134.Number of self-reported cancers,49168,0.13726060157492,0.0557104133909897,0.0280681913285799,0.24645301182126,0.0137545173102453
APOA2,Apolipoprotein A-II,Health and medical history,X135.Number of self-reported non-cancer illnesses,49169,0.248603831675392,0.0269674209782711,0.195747686557981,0.301459976792804,3.28994302553727e-20
APOA2,Apolipoprotein A-II,Health and medical history,"X136.Number of operations, self-reported",49169,0.100212318093392,0.0256695096179751,0.0499000792421608,0.150524556944623,9.49396877618879e-05
APOA2,Apolipoprotein A-II,Health and medical history,X137.Number of treatments or medications taken,49169,0.333061967514365,0.0264984159740058,0.281125072205314,0.384998862823416,4.23740130056873e-36
APOA2,Apolipoprotein A-II,Diet and food preferences,X1438.Bread intake,48704,-0.0155725008618403,0.00365812266957106,-0.0227424212941995,-0.00840258042948099,2.08160036094064e-05
APOA2,Apolipoprotein A-II,Diet and food preferences,X1458.Cereal intake,48120,-0.124090651251262,0.0266876165113164,-0.176398379613442,-0.071782922889082,3.34519463699747e-06
APOA2,Apolipoprotein A-II,Diet and food preferences,X1488.Tea intake,48406,0.00659568826697407,0.00360854361782724,-0.00047705722396731,0.0136684337579155,0.0675949320385426
APOA2,Apolipoprotein A-II,Diet and food preferences,X1498.Coffee intake,47572,-0.0924191934980789,0.0267843437814167,-0.144916507309656,-0.0399218796865021,0.00056078083138672
APOA2,Apolipoprotein A-II,Diet and food preferences,X1528.Water intake,47350,0.113212205226163,0.0269577722450445,0.0603749716258762,0.166049438826451,2.68606182374623e-05
APOA2,Apolipoprotein A-II,Lifestyle factors,X1568.Average weekly red wine intake,44281,-0.0510918787035732,0.0296969050104873,-0.109297812524128,0.00711405511698193,0.085371392596072
APOA2,Apolipoprotein A-II,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,44284,0.00810814066603513,0.0311688378202747,-0.0529827814617033,0.0691990627937736,0.794762188784029
APOA2,Apolipoprotein A-II,Lifestyle factors,X1588.Average weekly beer plus cider intake,44338,0.102778528650018,0.0310796728779903,0.0418623698091576,0.163694687490879,0.000945332829782366
APOA2,Apolipoprotein A-II,Lifestyle factors,X1598.Average weekly spirits intake,44282,0.0910060688288284,0.0320928513852091,0.0281040801138185,0.153908057543838,0.0045782256437687
APOA2,Apolipoprotein A-II,Lifestyle factors,X1608.Average weekly fortified wine intake,44314,0.0694316588324586,0.0571710295853112,-0.0426235591547515,0.181486876819669,0.224592167126495
APOA2,Apolipoprotein A-II,Lifestyle factors,X1737.Childhood sunburn occasions,43755,0.00639011003340165,0.0316395450911408,-0.0556233983452342,0.0684036184120375,0.839946073092498
APOA2,Apolipoprotein A-II,Health and medical history,X1807.Father's age at death,43910,-0.00577426806550543,0.00417302082852677,-0.0139533888894179,0.00240485275840705,0.166466164910512
APOA2,Apolipoprotein A-II,Health and medical history,X1845.Mother's age,36194,-0.0020002663145813,0.00932593119342807,-0.0202790914537003,0.0162785588245377,0.830175126775744
APOA2,Apolipoprotein A-II,Health and medical history,X1873.Number of full brothers,48820,-0.0192719318914297,0.0257520296542376,-0.0697459100137354,0.031202046230876,0.454248399488442
APOA2,Apolipoprotein A-II,Health and medical history,X1883.Number of full sisters,48821,-0.0132279395804051,0.0257987734908149,-0.0637935356224022,0.037337656461592,0.608142156450138
APOA2,Apolipoprotein A-II,Physical measures,X20015.Sitting height,48988,-0.026473453573587,0.00470547147248143,-0.0356961776596506,-0.0172507294875234,1.86748559340699e-08
APOA2,Apolipoprotein A-II,Cognitive function,X20016.Fluid intelligence score,35264,0.0199122529023377,0.0422632376958841,-0.0629236929815951,0.102748198786271,0.637550280501794
APOA2,Apolipoprotein A-II,Cognitive function,X20018.Prospective memory result,35567,0.0110864727149158,0.0567251124603992,-0.100094747707467,0.122267693137298,0.845052594161975
APOA2,Apolipoprotein A-II,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),35181,0.00553240878188854,0.0064495369561459,-0.00710868365215742,0.0181735012159345,0.391034491883231
APOA2,Apolipoprotein A-II,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),35186,-0.00121295013629846,0.00643291183771109,-0.0138214573382122,0.0113955570656153,0.850448334906524
APOA2,Apolipoprotein A-II,Cognitive function,X20023.Mean time to correctly identify matches,48914,0.0133341744017526,0.00370561359545638,0.00607117175465812,0.0205971770488471,0.000320976946496957
APOA2,Apolipoprotein A-II,Health and medical history,X20107#1.Illnesses of father_Heart disease,46176,-0.0114744467138695,0.00826807511584592,-0.0276798739409275,0.00473098051318845,0.165215102876181
APOA2,Apolipoprotein A-II,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,45796,-0.0148337054134372,0.0184859208595083,-0.0510661102980736,0.0213986994711991,0.422313855102278
APOA2,Apolipoprotein A-II,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,45761,-0.044923699272067,0.0242019742200671,-0.0923595687433986,0.00251217019926449,0.0634422152684083
APOA2,Apolipoprotein A-II,Health and medical history,X20107#12.Illnesses of father_Severe depression,45783,-0.0637163798592423,0.0218732426784357,-0.106587935508976,-0.0208448242095084,0.00358455335695916
APOA2,Apolipoprotein A-II,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,45804,-0.0283416314301813,0.0145896331002193,-0.056937312306611,0.000254049446248451,0.0520823752120793
APOA2,Apolipoprotein A-II,Health and medical history,X20107#2.Illnesses of father_Stroke,45946,7.65437220793155e-05,0.0105381062043768,-0.0205781444384991,0.0207312318826578,0.994204685772197
APOA2,Apolipoprotein A-II,Health and medical history,X20107#3.Illnesses of father_Lung cancer,45908,-0.0059173856279238,0.013358698576306,-0.0321004348374836,0.020265663581636,0.657799309647608
APOA2,Apolipoprotein A-II,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,45809,0.0183448187913474,0.0162690008015252,-0.013542422779642,0.0502320603623369,0.25950737393418
APOA2,Apolipoprotein A-II,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,45930,0.0121845171801659,0.0125064131417139,-0.0123280525775935,0.0366970869379252,0.329940299985553
APOA2,Apolipoprotein A-II,Health and medical history,X20107#8.Illnesses of father_High blood pressure,46001,0.0135329033879712,0.00937483840563653,-0.00484177988707641,0.0319075866630188,0.148887941669197
APOA2,Apolipoprotein A-II,Health and medical history,X20107#9.Illnesses of father_Diabetes,45874,-0.0173120047027599,0.0128331453586378,-0.0424649696056899,0.00784096020017018,0.177352355758869
APOA2,Apolipoprotein A-II,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46841,0.0018264222901598,0.00978582881180228,-0.0173538021809727,0.0210066467612923,0.851945362439119
APOA2,Apolipoprotein A-II,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46710,-0.00698252454034989,0.0137769350699954,-0.0339853172775409,0.0200202681968411,0.612282285325473
APOA2,Apolipoprotein A-II,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46640,-0.0191684041074648,0.0309951960075604,-0.0799189882822832,0.0415821800673536,0.536298777630235
APOA2,Apolipoprotein A-II,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46671,-0.00526205689981303,0.0163528646737099,-0.0373136716602844,0.0267895578606583,0.74762160125859
APOA2,Apolipoprotein A-II,Health and medical history,X20110#2.Illnesses of mother_Stroke,46794,0.0150260047134411,0.0110175378571216,-0.0065683694865172,0.0366203789133994,0.172639203929393
APOA2,Apolipoprotein A-II,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46713,0.0204196270980256,0.0184920543939497,-0.0158247995141159,0.0566640537101671,0.269504626826994
APOA2,Apolipoprotein A-II,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46677,0.0395194649453333,0.0165893856418909,0.00700426908722712,0.0720346608034395,0.0172191770919918
APOA2,Apolipoprotein A-II,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46685,-0.0198562272913959,0.0140809414259921,-0.0474548724863404,0.00774241790354868,0.158512850985634
APOA2,Apolipoprotein A-II,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46716,0.00748215949256412,0.0166308840512445,-0.0251143732478752,0.0400786922330034,0.652791192969221
APOA2,Apolipoprotein A-II,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46896,-0.00336710480363205,0.00841492509714135,-0.0198603579940291,0.013126148386765,0.68906186746123
APOA2,Apolipoprotein A-II,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46763,-0.030701129883727,0.0126900015488036,-0.0555735329193821,-0.00582872684807185,0.0155594622935426
APOA2,Apolipoprotein A-II,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,44208,-0.00798120304299974,0.0136102719231047,-0.0346573360122849,0.0186949299262854,0.557608334265192
APOA2,Apolipoprotein A-II,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,44081,-0.0109113196933994,0.0559634450885098,-0.120599672066879,0.0987770326800797,0.845417218166761
APOA2,Apolipoprotein A-II,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,44077,-0.0325051478624935,0.0531304993584745,-0.136640926605103,0.0716306308801165,0.540680217795456
APOA2,Apolipoprotein A-II,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,44127,0.0114598465619515,0.0176376223416144,-0.0231098932276127,0.0460295863515158,0.515870605585884
APOA2,Apolipoprotein A-II,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,44089,-0.0377291722189319,0.0320667192493459,-0.10057994194765,0.0251215975097862,0.239379875007496
APOA2,Apolipoprotein A-II,Health and medical history,X20111#2.Illnesses of siblings_Stroke,44120,0.00956061530790286,0.0226974548697516,-0.0349263962368104,0.0540476268526161,0.673600487742628
APOA2,Apolipoprotein A-II,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,44094,0.0739028470644561,0.026022019774727,0.0228996883059912,0.124906005822921,0.00451706117211684
APOA2,Apolipoprotein A-II,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,44100,0.0202846712804805,0.0252738221338348,-0.0292520201018358,0.0698213626627967,0.422220524278786
APOA2,Apolipoprotein A-II,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,44104,0.0102715587005711,0.0199110837138692,-0.0287541653786125,0.0492972827797547,0.605951584276678
APOA2,Apolipoprotein A-II,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,44122,0.021782631356056,0.0253447997367951,-0.0278931761280624,0.0714584388401743,0.390104626618432
APOA2,Apolipoprotein A-II,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,44263,-0.00133711721784284,0.010371183240878,-0.0216646363699638,0.0189904019342781,0.897417702491307
APOA2,Apolipoprotein A-II,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,44180,-0.00316015066395722,0.0143857274930225,-0.0313561765502814,0.0250358752223669,0.826128996134593
APOA2,Apolipoprotein A-II,Mental health,X20127.Neuroticism score,45136,-0.00493483587773479,0.0267387108171793,-0.0573427090794062,0.0474730373239366,0.853578204487756
APOA2,Apolipoprotein A-II,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,35264,0.053938088193704,0.0429013787233558,-0.0301486141040733,0.138024790491481,0.208704473263218
APOA2,Apolipoprotein A-II,Lifestyle factors,X20161.Pack years of smoking,35842,0.0141260739492994,0.00641216532551884,0.00155822991128252,0.0266939179873164,0.0276253163717104
APOA2,Apolipoprotein A-II,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,35842,0.0125688572573386,0.00632183243622312,0.000178065682341327,0.0249596488323359,0.04683083207924
APOA2,Apolipoprotein A-II,Cognitive function,X20191.Fluid intelligence score,33359,0.00387543764777989,0.0529919816127515,-0.0999888463132131,0.107739721608773,0.94170373748677
APOA2,Apolipoprotein A-II,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,33360,0.0301920171842747,0.053672651453364,-0.0750063796643189,0.135390414032868,0.573787357200205
APOA2,Apolipoprotein A-II,Cognitive function,X20240.Maximum digits remembered correctly,32915,0.002035859224285,0.056320114477646,-0.108351565151901,0.112423283600471,0.971166027902907
APOA2,Apolipoprotein A-II,Physical measures,X20255.Spirometry QC measure,43246,-0.0110148183304941,0.0331348539960561,-0.0759591321627641,0.0539294955017759,0.739573929491896
APOA2,Apolipoprotein A-II,Eye measures,X20261.avMSE,33205,0.00666141450682862,0.00797474394972903,-0.00896908363464028,0.0222919126482975,0.403584325569394
APOA2,Apolipoprotein A-II,Eye measures,X20262.Myopia diagnosis,33205,-0.0124026105504619,0.0634982720041646,-0.136859223678625,0.112054002577701,0.845149481155925
APOA2,Apolipoprotein A-II,NMR metabolomics,X20280.Glucose-lactate,39966,-0.00482420270227565,0.00473610003001365,-0.0141069587611024,0.0044585533565511,0.308413460737738
APOA2,Apolipoprotein A-II,NMR metabolomics,X20281.Spectrometer-corrected alanine,39987,-0.00366596132594269,0.00500856884810114,-0.0134827562682209,0.00615083361633554,0.464221540130911
APOA2,Apolipoprotein A-II,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,34935,-0.0208196176379393,0.0302144905312736,-0.0800400190792355,0.038400783803357,0.490810312874018
APOA2,Apolipoprotein A-II,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,34935,-0.143295699970998,0.0662169428481292,-0.273080907953332,-0.0135104919886652,0.0304990089086732
APOA2,Apolipoprotein A-II,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),34937,-0.031387637193026,0.0803399158311306,-0.188853872222042,0.12607859783599,0.696042878534301
APOA2,Apolipoprotein A-II,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),34937,-0.0316131382544921,0.0293594126474405,-0.0891575870434756,0.0259313105344913,0.281627011133619
APOA2,Apolipoprotein A-II,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),34937,0.0362463535701954,0.0413587687113724,-0.0448168331040945,0.117309540244485,0.380852030949241
APOA2,Apolipoprotein A-II,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,34938,-0.0738641147874799,0.0572908155417071,-0.186154113249226,0.038425883674266,0.197346524070627
APOA2,Apolipoprotein A-II,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,34938,-0.0688722986065309,0.0368984862834979,-0.141193331722187,0.00344873450912492,0.0620127614833523
APOA2,Apolipoprotein A-II,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,34938,-0.0775286919834322,0.0417477660206762,-0.159354313383957,0.00429692941709307,0.0633469807218956
APOA2,Apolipoprotein A-II,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,34938,-0.0513428363474617,0.061773244048753,-0.172418394683018,0.0697327219880942,0.405920164796825
APOA2,Apolipoprotein A-II,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,34938,-0.0394399419451675,0.0662446898994699,-0.169279534148129,0.0903996502577935,0.551619035876163
APOA2,Apolipoprotein A-II,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,34938,-0.034689313123871,0.0444427614776519,-0.121797125620069,0.0524184993723267,0.435102770895437
APOA2,Apolipoprotein A-II,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,34938,0.0385011767326407,0.0651622549375196,-0.0892168429448976,0.166219196410179,0.554641397881142
APOA2,Apolipoprotein A-II,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,34938,-0.111192232457567,0.0510722682845375,-0.211293878295261,-0.0110905866198736,0.0295057938551384
APOA2,Apolipoprotein A-II,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),34941,0.00480358415269483,0.0869923490149809,-0.165701419916668,0.175308588222057,0.955966156482814
APOA2,Apolipoprotein A-II,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),34941,-0.039452167021134,0.0393691688695925,-0.116615738005535,0.0377114039632672,0.316329575648607
APOA2,Apolipoprotein A-II,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),34941,-0.02852749731958,0.0502018220636515,-0.126923068564337,0.0698680739251769,0.569881128044812
APOA2,Apolipoprotein A-II,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,34941,0.0348194146421628,0.105816832816612,-0.172581577678397,0.242220406962722,0.742126007228419
APOA2,Apolipoprotein A-II,Diet and food preferences,X20600.Liking for adding salt to foods,35382,-0.0218288550615911,0.0441105287200521,-0.108285491352893,0.0646277812297109,0.620709897562229
APOA2,Apolipoprotein A-II,Diet and food preferences,X20601.Liking for aniseed,35382,0.0230031562627725,0.0437889742949617,-0.0628232333553524,0.108829545880897,0.599379027025207
APOA2,Apolipoprotein A-II,Diet and food preferences,X20602.Liking for apple juice,35382,-0.0588369004108584,0.0439375807599824,-0.144954558700424,0.0272807578787071,0.180582420903909
APOA2,Apolipoprotein A-II,Diet and food preferences,X20603.Liking for apples,35382,-0.0477072120603149,0.0449816266722615,-0.135871200337947,0.0404567762173176,0.288912585072457
APOA2,Apolipoprotein A-II,Diet and food preferences,X20604.Liking for asparagus,35382,-0.00742275348286254,0.0437937518504856,-0.0932585071098143,0.0784130001440892,0.865413596678448
APOA2,Apolipoprotein A-II,Diet and food preferences,X20605.Liking for aubergine,35382,0.0131565098285939,0.0435382793304819,-0.0721785176591506,0.0984915373163385,0.762522157189681
APOA2,Apolipoprotein A-II,Diet and food preferences,X20606.Liking for avocados,35382,0.136163123506357,0.0436916677766977,0.0505274546640298,0.221798792348685,0.00183805379728575
APOA2,Apolipoprotein A-II,Diet and food preferences,X20607.Liking for bacon,35382,-0.0430335172027205,0.0444202267070271,-0.130097161548494,0.0440301271430526,0.332688549158829
APOA2,Apolipoprotein A-II,Diet and food preferences,X20608.Liking for baked or steamed fish,35382,0.00367246805965339,0.0447132852116034,-0.0839655709550893,0.0913105070743961,0.934542812907619
APOA2,Apolipoprotein A-II,Diet and food preferences,X20609.Liking for bananas,35382,0.05338834782773,0.0451558050152861,-0.0351170300022309,0.141893725657691,0.2371225724273
APOA2,Apolipoprotein A-II,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35382,-0.125690546026883,0.0445171893855646,-0.21294423722259,-0.0384368548311766,0.00476535551218759
APOA2,Apolipoprotein A-II,Diet and food preferences,X20611.Liking for beef steak,35382,-0.0819573318021764,0.045205654561214,-0.170560414742156,0.00664575113780298,0.0698778438818698
APOA2,Apolipoprotein A-II,Diet and food preferences,X20612.Liking for beetroot,35382,0.0157114101850928,0.0439280687178161,-0.0703876045018267,0.101810424872012,0.720607260598045
APOA2,Apolipoprotein A-II,Diet and food preferences,X20613.Liking for bell pepper,35382,-0.0230108697858122,0.0434525294208114,-0.108177827450603,0.0621560878789782,0.596432023779329
APOA2,Apolipoprotein A-II,Diet and food preferences,X20614.Liking for bicycling,35382,0.112208771549343,0.0435958336662688,0.0267609375634562,0.19765660553523,0.010078694804695
APOA2,Apolipoprotein A-II,Diet and food preferences,X20615.Liking for biscuits,35382,-0.0239190881294779,0.0440473929687428,-0.110251978348214,0.0624138020892579,0.587126511242586
APOA2,Apolipoprotein A-II,Diet and food preferences,X20616.Liking for bitter foods,35382,0.0740592321814409,0.0433721898263223,-0.0109502598781507,0.159068724241033,0.0877697718007978
APOA2,Apolipoprotein A-II,Diet and food preferences,X20617.Liking for bitter or ale,35382,0.0903289269206792,0.0439507826158156,0.00418539299368068,0.176472460847678,0.0398951454935307
APOA2,Apolipoprotein A-II,Diet and food preferences,X20618.Liking for black olives,35382,0.0297869091687673,0.0441140736336828,-0.056676675153251,0.116250493490786,0.499556108901184
APOA2,Apolipoprotein A-II,Diet and food preferences,X20619.Liking for black pepper,35382,0.0101282054009341,0.044178365128653,-0.0764613902512258,0.0967178010530939,0.818675990105602
APOA2,Apolipoprotein A-II,Diet and food preferences,X20620.Liking for blue cheese,35382,0.142641273399637,0.0435195887512577,0.0573428794471723,0.227939667352102,0.00105208708462101
APOA2,Apolipoprotein A-II,Diet and food preferences,X20621.Liking for bolognese sauce,35382,-0.0541299330762249,0.0439895404693947,-0.140349432396239,0.0320895662437887,0.218545824367157
APOA2,Apolipoprotein A-II,Diet and food preferences,X20622.Liking for broad beans,35382,-0.0108448276227277,0.0442352887242454,-0.0975459935222487,0.0758563382767933,0.80633814972878
APOA2,Apolipoprotein A-II,Diet and food preferences,X20623.Liking for broccoli,35382,-0.0534878885150778,0.0444141801938243,-0.140539681694973,0.0335639046648178,0.228516675060869
APOA2,Apolipoprotein A-II,Diet and food preferences,X20624.Liking for brown rice,35382,0.0516657359179513,0.0438510758539352,-0.0342823727557616,0.137613844591664,0.238754655420716
APOA2,Apolipoprotein A-II,Diet and food preferences,X20625.Liking for brussel sprouts,35382,0.00578345798227482,0.0441247985778675,-0.0807011472303454,0.092268063194895,0.895723455835215
APOA2,Apolipoprotein A-II,Diet and food preferences,X20626.Liking for burgers (meat),35382,-0.141151850128892,0.0439471513590154,-0.227288266792563,-0.0550154334652222,0.00132497866535011
APOA2,Apolipoprotein A-II,Diet and food preferences,X20627.Liking for burn of spicy foods,35382,-0.00480111150783998,0.0430025738023946,-0.0890861561605334,0.0794839331448534,0.911106554605714
APOA2,Apolipoprotein A-II,Diet and food preferences,X20628.Liking for butter on bread,35382,-0.069018739796886,0.0445989869002701,-0.156432754121415,0.0183952745276434,0.121779680330205
APOA2,Apolipoprotein A-II,Diet and food preferences,X20629.Liking for butternut squash,35382,-0.0607226793054699,0.0434714267296027,-0.145926675695491,0.0244813170845513,0.162507098801149
APOA2,Apolipoprotein A-II,Diet and food preferences,X20630.Liking for cabbage,35382,-0.0252616535596085,0.0441577203355285,-0.111810785417244,0.0612874782980273,0.56728822291957
APOA2,Apolipoprotein A-II,Diet and food preferences,X20631.Liking for cake,35382,-0.00481797809064583,0.0440198338001069,-0.0910968523388553,0.0814608961575636,0.912848688945759
APOA2,Apolipoprotein A-II,Diet and food preferences,X20632.Liking for cake icing,35382,-0.0203469939856174,0.0437555447776031,-0.10610786174972,0.0654138737784847,0.64193551134325
APOA2,Apolipoprotein A-II,Diet and food preferences,X20633.Liking for capers,35382,0.024298334281593,0.0438416324565523,-0.0616312653332495,0.110227933896436,0.579439961207644
APOA2,Apolipoprotein A-II,Diet and food preferences,X20634.Liking for cauliflower,35382,0.0230277089220527,0.0445163047343446,-0.0642242483572627,0.110279666201368,0.604972669938458
APOA2,Apolipoprotein A-II,Diet and food preferences,X20635.Liking for cereal or granola bar,35382,-0.00523188717645063,0.0436975020839203,-0.0908789912609344,0.0804152169080331,0.904700853187995
APOA2,Apolipoprotein A-II,Diet and food preferences,X20636.Liking for cheesecake,35382,-0.0285164694202487,0.0439173526752382,-0.114594480663716,0.0575615418232182,0.516152784704786
APOA2,Apolipoprotein A-II,Diet and food preferences,X20637.Liking for cherries,35382,0.0273564738125962,0.0446649677424055,-0.0601868629625186,0.114899810587711,0.540239687192501
APOA2,Apolipoprotein A-II,Diet and food preferences,X20638.Liking for chicken,35382,-0.0686972748279464,0.045091033595325,-0.157075700674783,0.0196811510188905,0.127674331504832
APOA2,Apolipoprotein A-II,Diet and food preferences,X20639.Liking for chilli pepper,35382,0.0121973313684495,0.0435352850616524,-0.0731318273523891,0.0975264900892882,0.779354747341385
APOA2,Apolipoprotein A-II,Diet and food preferences,X20640.Liking for chips or french fries,35382,-0.0201223441903726,0.0445401762060769,-0.107421089554283,0.0671764011735382,0.651442214311708
APOA2,Apolipoprotein A-II,Diet and food preferences,X20641.Liking for cigarette smoking,35382,0.0834112381931588,0.0687719924499122,-0.0513818670086691,0.218204343394987,0.225223207809921
APOA2,Apolipoprotein A-II,Diet and food preferences,X20642.Liking for cod,35382,-0.0759588054281731,0.0449765678663784,-0.164112878446275,0.0121952675899286,0.0912936608771637
APOA2,Apolipoprotein A-II,Diet and food preferences,X20643.Liking for coffee with sugar,35382,-0.0545587944419977,0.0456035624082041,-0.143941776762078,0.0348241878780823,0.231593563487347
APOA2,Apolipoprotein A-II,Diet and food preferences,X20644.Liking for coffee without sugar,35382,0.0587915996003386,0.0444924688639908,-0.0284136393730833,0.145996838573761,0.186418268823229
APOA2,Apolipoprotein A-II,Diet and food preferences,X20645.Liking for coriander,35382,-0.0311322324087407,0.0438910241679579,-0.117158639777938,0.0548941749604569,0.478158093671474
APOA2,Apolipoprotein A-II,Diet and food preferences,X20646.Liking for corn flakes,35382,-0.0579473025898248,0.0436459118592902,-0.143493289834034,0.0275986846543841,0.184332386730266
APOA2,Apolipoprotein A-II,Diet and food preferences,X20647.Liking for cream,35382,-0.118936307762792,0.0440984350800482,-0.205369240519687,-0.0325033750058977,0.007012693315949
APOA2,Apolipoprotein A-II,Diet and food preferences,X20648.Liking for croissant,35382,-0.031693618772282,0.0440708357374711,-0.118072456817725,0.0546852192731613,0.472072233646816
APOA2,Apolipoprotein A-II,Diet and food preferences,X20649.Liking for cucumber,35382,-0.0483050500224367,0.0437511674101795,-0.134057338146388,0.0374472381015151,0.269595070455456
APOA2,Apolipoprotein A-II,Diet and food preferences,X20650.Liking for curry,35382,-0.0492049260930627,0.0447380485818786,-0.136891501313545,0.0384816491274193,0.271438683067252
APOA2,Apolipoprotein A-II,Diet and food preferences,X20651.Liking for dairy products,35382,-0.0181698128622173,0.0446860221205138,-0.105754416218424,0.0694147904939897,0.684306815459702
APOA2,Apolipoprotein A-II,Diet and food preferences,X20652.Liking for dark chocolate,35382,-0.0216337784734408,0.0442458931476182,-0.108355729042772,0.0650881720958909,0.624896943668156
APOA2,Apolipoprotein A-II,Diet and food preferences,X20653.Liking for diet fizzy drinks,35382,-0.0789546568739758,0.044308010935706,-0.16579835830796,0.00788904456000798,0.0748021868358323
APOA2,Apolipoprotein A-II,Diet and food preferences,X20654.Liking for dried fruit,35382,-0.090245350813138,0.0439790194054684,-0.176444228847856,-0.00404647277841991,0.0402071307572836
APOA2,Apolipoprotein A-II,Diet and food preferences,X20655.Liking for eggs,35382,-0.0382890432050755,0.0452453581806828,-0.126969945239214,0.0503918588290629,0.397441233428484
APOA2,Apolipoprotein A-II,Diet and food preferences,X20656.Liking for exercising alone,35382,0.170607594026902,0.043671759849669,0.0850109447215503,0.256204243332253,9.4519436414459e-05
APOA2,Apolipoprotein A-II,Diet and food preferences,X20657.Liking for exercising with others,35382,0.121619194473897,0.043664551233985,0.0360366740552861,0.207201714892507,0.00536256199819602
APOA2,Apolipoprotein A-II,Diet and food preferences,X20658.Liking for extra virgin olive oil,35382,-0.022635352265262,0.0443561749515303,-0.109573455170261,0.0643027506397374,0.609851675947764
APOA2,Apolipoprotein A-II,Diet and food preferences,X20659.Liking for fatty foods,35382,-0.0557638795673298,0.0435872844987853,-0.141194957184949,0.0296671980502895,0.200813724363368
APOA2,Apolipoprotein A-II,Diet and food preferences,X20660.Liking for fresh tomatoes,35382,-0.064089759959073,0.0455822176116684,-0.153430906477943,0.0252513865597971,0.159762428627367
APOA2,Apolipoprotein A-II,Diet and food preferences,X20661.Liking for fried chicken,35382,-0.100546829905817,0.0437700152649163,-0.186336059825053,-0.0147575999865812,0.0216398683931217
APOA2,Apolipoprotein A-II,Diet and food preferences,X20662.Liking for fried or battered fish,35382,-0.108720782222485,0.0444683305103531,-0.195878710022777,-0.0215628544221925,0.0145143897351282
APOA2,Apolipoprotein A-II,Diet and food preferences,X20663.Liking for fruit,35382,-0.0405711461049131,0.0466270949102101,-0.131960252128925,0.0508179599190987,0.384265919487391
APOA2,Apolipoprotein A-II,Diet and food preferences,X20664.Liking for garlic,35382,-0.0102482963728998,0.0444157838762009,-0.0973032327702537,0.076806640024454,0.817527291789267
APOA2,Apolipoprotein A-II,Diet and food preferences,X20665.Liking for gherkins,35382,0.0371111558136873,0.0439364230151561,-0.0490042332960187,0.123226544923393,0.398332862157008
APOA2,Apolipoprotein A-II,Diet and food preferences,X20666.Liking for globe artichoke,35382,0.0626295086726065,0.0439544916577864,-0.0235212949766549,0.148780312321868,0.154240384452847
APOA2,Apolipoprotein A-II,Diet and food preferences,X20667.Liking for goat's cheese,35382,0.0484269991739601,0.0436661984275573,-0.0371587497440523,0.134012748091972,0.267457850635513
APOA2,Apolipoprotein A-II,Diet and food preferences,X20668.Liking for going to a cafe,35382,-0.0482042185147351,0.0434583046191814,-0.133382495568331,0.0369740585388605,0.267380644736184
APOA2,Apolipoprotein A-II,Diet and food preferences,X20669.Liking for going to the gym,35382,0.0997471263229549,0.0435645067790101,0.0143606930360952,0.185133559609815,0.0220726901167855
APOA2,Apolipoprotein A-II,Diet and food preferences,X20670.Liking for going to the pub,35382,0.0544483256724812,0.0440502225434314,-0.0318901105126444,0.140786761857607,0.216482437818529
APOA2,Apolipoprotein A-II,Diet and food preferences,X20671.Liking for grapefruit,35382,0.0364744349021492,0.0432793742917103,-0.048353138709603,0.121302008513901,0.399388443173939
APOA2,Apolipoprotein A-II,Diet and food preferences,X20672.Liking for green olives,35382,0.0403322469571869,0.0443431600867128,-0.0465803468127702,0.127244840727144,0.363093126453178
APOA2,Apolipoprotein A-II,Diet and food preferences,X20673.Liking for haddock,35382,0.0495022254589793,0.0453717627193898,-0.0394264294710246,0.138430880388983,0.275295863191977
APOA2,Apolipoprotein A-II,Diet and food preferences,X20674.Liking for ham,35382,-0.110826518613998,0.044569463669244,-0.198182667405716,-0.0234703698222798,0.0129208646032864
APOA2,Apolipoprotein A-II,Diet and food preferences,X20675.Liking for hard cheese,35382,0.0456292164188318,0.0447379550407928,-0.0420571754611221,0.133315608298786,0.30780197020197
APOA2,Apolipoprotein A-II,Diet and food preferences,X20676.Liking for herring,35382,0.0221910145683938,0.0440438010648633,-0.0641348355187383,0.108516864655526,0.61439042956674
APOA2,Apolipoprotein A-II,Diet and food preferences,X20677.Liking for honey,35382,-0.0385751710361059,0.0439326783613467,-0.124683220624345,0.0475328785521336,0.379946708476657
APOA2,Apolipoprotein A-II,Diet and food preferences,X20678.Liking for horseradish or wasabi,35382,-0.0254200298110986,0.0437511979840215,-0.111172377859781,0.0603323182375834,0.561250793217253
APOA2,Apolipoprotein A-II,Diet and food preferences,X20679.Liking for ice cream,35382,-0.105144836444857,0.0442128473884225,-0.191802017326165,-0.0184876555635494,0.0174272659709242
APOA2,Apolipoprotein A-II,Diet and food preferences,X20680.Liking for jam,35382,-0.0692056685928525,0.0437328522729146,-0.154922059047765,0.0165107218620601,0.113590353154741
APOA2,Apolipoprotein A-II,Diet and food preferences,X20681.Liking for kiwi fruit,35382,-0.0415527239822013,0.0439453424587497,-0.127685595201351,0.0445801472369481,0.344409502121516
APOA2,Apolipoprotein A-II,Diet and food preferences,X20682.Liking for lager,35382,0.0170006188596441,0.0435894311992583,-0.0684346662909021,0.10243590401019,0.69653624595491
APOA2,Apolipoprotein A-II,Diet and food preferences,X20683.Liking for lamb,35382,-0.0676051686187775,0.0452138027562781,-0.156224222021083,0.0210138847835276,0.134900240737919
APOA2,Apolipoprotein A-II,Diet and food preferences,X20684.Liking for lemons,35382,0.0224998461539318,0.0433126018538298,-0.0623928534795745,0.107392545787438,0.603445997170297
APOA2,Apolipoprotein A-II,Diet and food preferences,X20685.Liking for lentils or beans,35382,-0.00533448380898854,0.0443540394215648,-0.0922684010752555,0.0815994334572784,0.904272415989215
APOA2,Apolipoprotein A-II,Diet and food preferences,X20686.Liking for liver,35382,-0.0530970627936648,0.0441938809656443,-0.139717069486328,0.033522943898998,0.229615853737144
APOA2,Apolipoprotein A-II,Diet and food preferences,X20687.Liking for mackerel,35382,0.102264529179105,0.0443147820585176,0.0154075563444106,0.1891215020138,0.0210466948258178
APOA2,Apolipoprotein A-II,Diet and food preferences,X20688.Liking for marzipan,35382,-0.0356542885803577,0.0436567325922488,-0.121221484461165,0.04991290730045,0.414130774729098
APOA2,Apolipoprotein A-II,Diet and food preferences,X20689.Liking for mayonnaise,35382,0.0411503541545602,0.04353542214631,-0.0441790732522073,0.126479781561328,0.344582604911471
APOA2,Apolipoprotein A-II,Diet and food preferences,X20690.Liking for melon,35382,-0.0679775940810258,0.0443715928908866,-0.154945916147163,0.0189907279851119,0.125567393882181
APOA2,Apolipoprotein A-II,Diet and food preferences,X20691.Liking for milk chocolate,35382,-0.00508799197106495,0.0441120114164358,-0.0915475343472791,0.0813715504051492,0.908177031036959
APOA2,Apolipoprotein A-II,Diet and food preferences,X20692.Liking for mushrooms,35382,-0.0153266474884898,0.0453250536316842,-0.104163752606591,0.0735104576296112,0.735260956035023
APOA2,Apolipoprotein A-II,Diet and food preferences,X20694.Liking for orange juice,35382,0.0124750040948604,0.0443980633708955,-0.0745452001120947,0.0994952083018155,0.77873369631859
APOA2,Apolipoprotein A-II,Diet and food preferences,X20695.Liking for oranges,35382,-0.0836355311213985,0.0444256239917402,-0.170709754145209,0.0034386919024124,0.0597978771583622
APOA2,Apolipoprotein A-II,Diet and food preferences,X20696.Liking for pasta,35382,-0.0753702607089581,0.0445757143011062,-0.162738660739126,0.0119981393212101,0.0909139759108488
APOA2,Apolipoprotein A-II,Diet and food preferences,X20697.Liking for pears,35382,-0.0304248221157931,0.0443966822047862,-0.117442319237174,0.0565926750055878,0.493181270530801
APOA2,Apolipoprotein A-II,Diet and food preferences,X20698.Liking for pizza,35382,-0.128009492487933,0.0437549111986365,-0.21376911843726,-0.042249866538605,0.00344931106544314
APOA2,Apolipoprotein A-II,Diet and food preferences,X20699.Liking for plain yogurt,35382,-0.0680797082650799,0.0441062618790834,-0.154527981548083,0.0183685650179235,0.122746919883344
APOA2,Apolipoprotein A-II,Diet and food preferences,X20700.Liking for plums,35382,-0.0342584867995471,0.0444468137490953,-0.121374241747774,0.0528572681486798,0.440867274646494
APOA2,Apolipoprotein A-II,Diet and food preferences,X20701.Liking for pollock,35382,0.0266693233804824,0.0438842128926295,-0.0593437338890714,0.112682380650036,0.543393427170215
APOA2,Apolipoprotein A-II,Diet and food preferences,X20702.Liking for pork chop,35382,-0.116351688835405,0.0441106084728805,-0.202808481442251,-0.029894896228559,0.00836548112223208
APOA2,Apolipoprotein A-II,Diet and food preferences,X20703.Liking for porridge,35382,0.00143525633711727,0.0439327470077627,-0.0846729277980976,0.0875434404723322,0.973939191447595
APOA2,Apolipoprotein A-II,Diet and food preferences,X20704.Liking for potato crisps,35382,-0.0259109315291152,0.0440323462594649,-0.112214330197666,0.0603924671394361,0.556248423261379
APOA2,Apolipoprotein A-II,Diet and food preferences,X20705.Liking for potatoes,35382,0.000861302221683134,0.0445400119832642,-0.0864371212655146,0.0881597257088809,0.984572263919015
APOA2,Apolipoprotein A-II,Diet and food preferences,X20706.Liking for prawns,35382,0.0263429969490778,0.0445869441148471,-0.0610474135160226,0.113733407414178,0.554658663715793
APOA2,Apolipoprotein A-II,Diet and food preferences,X20707.Liking for raw carrots,35382,0.0603589026583378,0.0438446638873513,-0.0255766385608707,0.146294443877546,0.168664957550654
APOA2,Apolipoprotein A-II,Diet and food preferences,X20708.Liking for red meat,35382,-0.104630846920594,0.0448997596553333,-0.192634375845047,-0.0166273179961408,0.0198184171218301
APOA2,Apolipoprotein A-II,Diet and food preferences,X20709.Liking for red wine,35382,0.0403082338998882,0.0445489112573185,-0.047007632164456,0.127624099964232,0.365599026623876
APOA2,Apolipoprotein A-II,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35382,-0.0783240353178377,0.0441452416140621,-0.164848708881399,0.00820063824572399,0.0760691916481693
APOA2,Apolipoprotein A-II,Diet and food preferences,X20711.Liking for roast chicken,35382,-0.0947556973796339,0.0451832188635609,-0.183314806352213,-0.0061965884070545,0.0360178492532355
APOA2,Apolipoprotein A-II,Diet and food preferences,X20712.Liking for salad dressing,35382,-0.0230849901611763,0.0441404246284868,-0.10960022243301,0.0634302421106578,0.60099848577287
APOA2,Apolipoprotein A-II,Diet and food preferences,X20713.Liking for salad leaves,35382,0.0188986422253035,0.0443123155083368,-0.0679534961710365,0.105750780621644,0.669766314584453
APOA2,Apolipoprotein A-II,Diet and food preferences,X20714.Liking for salami,35382,-0.0225643471479607,0.0438820330725348,-0.108573131970129,0.0634444376742074,0.607125666438722
APOA2,Apolipoprotein A-II,Diet and food preferences,X20715.Liking for salmon,35382,-0.0280034641823626,0.0451203695965844,-0.116439388591668,0.0604324602269428,0.534858010771005
APOA2,Apolipoprotein A-II,Diet and food preferences,X20716.Liking for salty foods,35382,0.017530929211691,0.0435366088298627,-0.0678008240948399,0.102862682518222,0.687202989168401
APOA2,Apolipoprotein A-II,Diet and food preferences,X20717.Liking for salty pretzels,35382,-0.0396953990784419,0.0435909404545615,-0.125133642369382,0.0457428442124985,0.36252057636871
APOA2,Apolipoprotein A-II,Diet and food preferences,X20718.Liking for sardines,35382,0.0812549882780839,0.0439891802839783,-0.0049638050785135,0.167473781634681,0.064767757676965
APOA2,Apolipoprotein A-II,Diet and food preferences,X20719.Liking for sausages (meat),35382,-0.0785854124324557,0.0445467551147689,-0.165897052457403,0.00872622759249121,0.0777583963298289
APOA2,Apolipoprotein A-II,Diet and food preferences,X20720.Liking for savoury biscuits,35382,0.065650608372927,0.0437811109252671,-0.0201603690405966,0.151461585786451,0.133785647304734
APOA2,Apolipoprotein A-II,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35382,0.0770215107053555,0.0439535842994359,-0.00912751452153897,0.16317053593225,0.0797610519978059
APOA2,Apolipoprotein A-II,Diet and food preferences,X20722.Liking for skimmed milk,35382,0.00811335908042196,0.0437714195141906,-0.0776786231673916,0.0939053413282355,0.852954223525615
APOA2,Apolipoprotein A-II,Diet and food preferences,X20723.Liking for smoked fish,35382,0.0397884140160321,0.0445196832898532,-0.0474701652320801,0.127046993264144,0.37150007889275
APOA2,Apolipoprotein A-II,Diet and food preferences,X20724.Liking for soft cheese,35382,2.87058461083887e-05,0.0436181026285543,-0.085462775305858,0.0855201869980748,0.999474917454389
APOA2,Apolipoprotein A-II,Diet and food preferences,X20725.Liking for soy sauce,35382,-0.00504267089768708,0.0439485463398002,-0.0911818217236954,0.0810964799283213,0.908654344084071
APOA2,Apolipoprotein A-II,Diet and food preferences,X20726.Liking for soya milk,35382,0.0133582665290432,0.0438600675339674,-0.0726074658375329,0.0993239988956193,0.760706402340275
APOA2,Apolipoprotein A-II,Diet and food preferences,X20727.Liking for spicy foods,35382,-0.0325249980490173,0.0439119593130701,-0.118592438302635,0.0535424422046002,0.458909187191202
APOA2,Apolipoprotein A-II,Diet and food preferences,X20728.Liking for spinach,35382,-0.0445980816360764,0.0441859265703288,-0.131202497713921,0.0420063344417681,0.312853534232673
APOA2,Apolipoprotein A-II,Diet and food preferences,X20729.Liking for spirits,35382,0.0733324741814739,0.0435576587330169,-0.0120405369352392,0.158705485298187,0.0923104099826402
APOA2,Apolipoprotein A-II,Diet and food preferences,X20730.Liking for strawberries,35382,-0.0993838088091608,0.0453027985524136,-0.188177293971891,-0.0105903236464302,0.0282859852977754
APOA2,Apolipoprotein A-II,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35382,-0.0733882048275641,0.0444498682580494,-0.160509946613341,0.0137335369582127,0.0987781730317664
APOA2,Apolipoprotein A-II,Diet and food preferences,X20732.Liking for sweet foods,35382,-0.0879983616575611,0.0434609502507684,-0.173181824149067,-0.00281489916605508,0.0429303019514637
APOA2,Apolipoprotein A-II,Diet and food preferences,X20733.Liking for taking the stairs,35382,0.0796889006126346,0.0447346525988239,-0.00799101848106029,0.167368819706329,0.074897070884635
APOA2,Apolipoprotein A-II,Diet and food preferences,X20734.Liking for tea with sugar,35382,-0.0243099133794409,0.0477667863133563,-0.117932814553619,0.0693129877947374,0.610818414436771
APOA2,Apolipoprotein A-II,Diet and food preferences,X20735.Liking for tea without sugar,35382,0.0144556313836966,0.0446239355501236,-0.0730072822945458,0.101918545061939,0.745990854602904
APOA2,Apolipoprotein A-II,Diet and food preferences,X20736.Liking for tomato ketchup,35382,-0.0150193551401343,0.0437602440964554,-0.100789433569187,0.0707507232889184,0.731444228130417
APOA2,Apolipoprotein A-II,Diet and food preferences,X20737.Liking for tinned tuna,35382,-0.00375315794068587,0.0440769418274399,-0.0901439639224681,0.0826376480410963,0.932144542681576
APOA2,Apolipoprotein A-II,Diet and food preferences,X20738.Liking for turnip (white),35382,-0.00986345276703329,0.0438374350030029,-0.095784825372919,0.0760579198388524,0.821985531611758
APOA2,Apolipoprotein A-II,Diet and food preferences,X20739.Liking for vegetables,35382,0.00699068022672473,0.0457470140396252,-0.0826734672909407,0.0966548277443902,0.878551301432166
APOA2,Apolipoprotein A-II,Diet and food preferences,X20740.Liking for vinegar,35382,-0.0755626121752637,0.0436564647061931,-0.161129282999402,0.0100040586488748,0.0835247996941747
APOA2,Apolipoprotein A-II,Diet and food preferences,X20741.Liking for watching television,35382,-0.0107093834980035,0.0443230149952529,-0.0975824928886991,0.0761637258926922,0.809080948193103
APOA2,Apolipoprotein A-II,Diet and food preferences,X20742.Liking for whisky,35382,0.0463244343797397,0.0438874344650484,-0.0396949371717552,0.132343805931235,0.291221367426963
APOA2,Apolipoprotein A-II,Diet and food preferences,X20743.Liking for white bread,35382,-0.0524219597823732,0.0439171017922688,-0.13849947929522,0.0336555597304738,0.232653940031581
APOA2,Apolipoprotein A-II,Diet and food preferences,X20744.Liking for white rice,35382,-0.101061164870437,0.0440592850809329,-0.187417363629065,-0.0147049661118081,0.021835102092229
APOA2,Apolipoprotein A-II,Diet and food preferences,X20745.Liking for white wine,35382,-0.0309072174022653,0.0436289190505259,-0.116419898741296,0.0546054639367654,0.478714283029893
APOA2,Apolipoprotein A-II,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35382,-0.040456384752863,0.0443098005120935,-0.127303593756566,0.0463908242508402,0.361256798186266
APOA2,Apolipoprotein A-II,Diet and food preferences,X20747.Liking for whole milk,35382,-0.0660285389557589,0.0439530364290973,-0.15217649035679,0.0201194124452719,0.133078647041883
APOA2,Apolipoprotein A-II,Diet and food preferences,X20748.Liking for wholemeal bread,35382,0.0147508076103824,0.0455525738972072,-0.0745322372281436,0.104033852448908,0.746084758540282
APOA2,Apolipoprotein A-II,Diet and food preferences,X20749.Liking for working up a sweat,35382,0.108008438904685,0.0436903050611244,0.0223754409848809,0.193641436824488,0.0134551757489222
APOA2,Apolipoprotein A-II,Physical measures,X21001.Body mass index (BMI),49046,-0.233726247916086,0.0188274444520849,-0.270628039042172,-0.196824456789999,2.93558748620697e-35
APOA2,Apolipoprotein A-II,Physical measures,X21002.Weight,49073,-0.0526115969064744,0.00909609989176752,-0.0704399526943387,-0.03478324111861,7.40191180052187e-09
APOA2,Apolipoprotein A-II,Physical measures,X21021.Pulse wave Arterial Stiffness index,35551,-0.0164688104639606,0.00690738172634952,-0.0300072786476056,-0.00293034228031552,0.0171414095335295
APOA2,Apolipoprotein A-II,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,35221,-0.00862110418511843,0.0483721871057817,-0.10343059091245,0.0861883825422136,0.858552202082023
APOA2,Apolipoprotein A-II,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,35223,0.0379690636507145,0.0495404523531512,-0.0591302229614619,0.135068350262891,0.443450520863474
APOA2,Apolipoprotein A-II,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,35225,0.0085245490004926,0.0477515857165931,-0.0850685590040298,0.102117657005015,0.85832113053741
APOA2,Apolipoprotein A-II,Health and medical history,X21040.Satisfaction with bowel habits,35200,0.000101598875251401,0.0442532125732647,-0.0866346977683475,0.0868378955188503,0.998168245348189
APOA2,Apolipoprotein A-II,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,35197,-0.0362241495294095,0.0486593270774307,-0.131596430601174,0.0591481315423548,0.456634393299615
APOA2,Apolipoprotein A-II,Health and medical history,X21042.Greatest number of times bowels opened per day,35197,-0.033544799887239,0.048002984012767,-0.127630648552262,0.0605410487777843,0.484697569375802
APOA2,Apolipoprotein A-II,Health and medical history,X21043.Least number of times bowels opened per week,35167,-0.0334565823386338,0.0481178457209707,-0.127767559951736,0.0608543952744689,0.486888740013738
APOA2,Apolipoprotein A-II,Health and medical history,X21044.Average number of times bowels opened per day,35180,-0.0339247619303489,0.052438435272098,-0.136704095063661,0.0688545712029632,0.51769040062773
APOA2,Apolipoprotein A-II,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,35228,0.0233794278292174,0.0484486825312279,-0.0715799899319893,0.118338845590424,0.629423662163306
APOA2,Apolipoprotein A-II,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,35223,-0.00175554310296354,0.0483544104801821,-0.0965301876441204,0.0930191014381933,0.971039660028564
APOA2,Apolipoprotein A-II,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,35227,0.0749679240064067,0.0562077439892995,-0.0351992542126203,0.185135102225434,0.182326714789836
APOA2,Apolipoprotein A-II,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,35227,0.0963380743071626,0.069376924433244,-0.0396406975819956,0.232316846196321,0.16499549246246
APOA2,Apolipoprotein A-II,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,35226,0.0729601684160879,0.0590038007193394,-0.0426872809938173,0.188607617825993,0.216304204620796
APOA2,Apolipoprotein A-II,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,35224,-0.182453418459252,0.140026510102486,-0.456905378260126,0.0919985413416208,0.192622801428913
APOA2,Apolipoprotein A-II,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,35228,0.0287587025848553,0.0597778070805948,-0.0884057992931106,0.145923204462821,0.630466071701056
APOA2,Apolipoprotein A-II,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,35226,-0.0143634788451836,0.0545375391067764,-0.121257055494465,0.0925300978040981,0.792274630836359
APOA2,Apolipoprotein A-II,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,35101,0.0711139644619366,0.0549584028141483,-0.0366045050537942,0.178832433977667,0.195725284084178
APOA2,Apolipoprotein A-II,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,35224,0.104533476399609,0.0490759535280355,0.00834460748465961,0.200722345314559,0.033205518146744
APOA2,Apolipoprotein A-II,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,35227,-0.0157805275326002,0.0845516575367445,-0.181501776304619,0.149940721239419,0.851950413651856
APOA2,Apolipoprotein A-II,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,35228,0.061743459660268,0.0482869673798554,-0.0328989964042486,0.156385915724785,0.201055415914965
APOA2,Apolipoprotein A-II,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,35227,0.0463861467335486,0.0483602293748739,-0.0483999028412042,0.141172196308301,0.337503260009182
APOA2,Apolipoprotein A-II,Working and living environment,X21100.Water hardness (USGS classification),48933,-0.0401572622302478,0.0260205222033318,-0.0911574857487781,0.0108429612882825,0.122775521817755
APOA2,Apolipoprotein A-II,Lifestyle factors,X2139.Age first had sexual intercourse,46477,-0.00482880157935882,0.00371484090808091,-0.0121098897591974,0.00245228660047976,0.193663088859015
APOA2,Apolipoprotein A-II,Health and medical history,X2149.Lifetime number of sexual partners,45004,-0.00280128331669086,0.0299203623763656,-0.0614451935743674,0.0558426269409856,0.92540847491663
APOA2,Apolipoprotein A-II,Physical activities,X22032.IPAQ activity group,45775,0.0777137053607856,0.0283627705006905,0.0221226751794322,0.133304735542139,0.00615045167838966
APOA2,Apolipoprotein A-II,Physical activities,X22033.Summed days activity,46117,0.0114308351418007,0.00370951262607471,0.00416019039469428,0.0187014798889071,0.00206285172777981
APOA2,Apolipoprotein A-II,Physical activities,X22034.Summed minutes activity,45775,0.00465319778592452,0.00374825894539595,-0.00269338974705155,0.0119997853189006,0.21446422308589
APOA2,Apolipoprotein A-II,Physical activities,X22037.MET minutes per week for walking,45160,0.00246447604556574,0.00383387852235365,-0.00504992585824742,0.00997887794937891,0.520352807722998
APOA2,Apolipoprotein A-II,Physical activities,X22038.MET minutes per week for moderate activity,45775,0.00496025816005777,0.00380245202809135,-0.00249254781500127,0.0124130641351168,0.192084269418943
APOA2,Apolipoprotein A-II,Physical activities,X22039.MET minutes per week for vigorous activity,45775,0.0873865996748097,0.0283603194846827,0.0318003734848316,0.142972825864788,0.00206426161083789
APOA2,Apolipoprotein A-II,Physical activities,X22040.Summed MET minutes per week for all activity,45160,0.00940483182795101,0.00379511846468031,0.0019663996371776,0.0168432640187244,0.0132168518738587
APOA2,Apolipoprotein A-II,Eye measures,X2217.Age started wearing glasses or contact lenses,45804,-0.00658421126005561,0.00390494329397055,-0.0142379001162379,0.00106947759612667,0.0917904130672886
APOA2,Apolipoprotein A-II,Working and living environment,X22501.Year ended full time education,33333,0.0228614144609878,0.016947504320938,-0.0103556940080507,0.0560785229300262,0.177416071185269
APOA2,Apolipoprotein A-II,Lifestyle factors,X22506.Tobacco smoking,33301,0.0794308187155311,0.106087213997047,-0.12850012071868,0.287361758149742,0.45405664319887
APOA2,Apolipoprotein A-II,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,47883,0.286494039276836,0.0798678507041529,0.129953051896696,0.443035026656975,0.000335202357880626
APOA2,Apolipoprotein A-II,Physical measures,X23098.Weight,48693,-0.0497428939679977,0.00917381874609804,-0.0677235787103498,-0.0317622092256455,5.95265556982197e-08
APOA2,Apolipoprotein A-II,Physical measures,X23099.Body fat percentage,48662,-0.0296812142663195,0.0082134421424949,-0.0457795608656095,-0.0135828676670295,0.000302553937506048
APOA2,Apolipoprotein A-II,Physical measures,X23100.Whole body fat mass,48623,-0.0443490002654928,0.00820001076988244,-0.0604210213744624,-0.0282769791565232,6.43161627917677e-08
APOA2,Apolipoprotein A-II,Physical measures,X23101.Whole body fat-free mass,48688,-0.0199695649516909,0.0079382457543523,-0.0355285266302214,-0.0044106032731604,0.0118902474858964
APOA2,Apolipoprotein A-II,Physical measures,X23102.Whole body water mass,48693,-0.0194135603162274,0.00791629765181718,-0.0349295037137891,-0.00389761691866574,0.0142009585989616
APOA2,Apolipoprotein A-II,Physical measures,X23104.Body mass index (BMI),48693,-0.21315237983692,0.018552498934889,-0.249515277749303,-0.176789481924538,1.86225400534022e-30
APOA2,Apolipoprotein A-II,Physical measures,X23105.Basal metabolic rate,48693,-0.0241257546789163,0.00824032942586559,-0.0402768003536129,-0.00797470900421979,0.00341790056321401
APOA2,Apolipoprotein A-II,Physical measures,X23106.Impedance of whole body,48693,0.0134112008449513,0.00650173599347468,0.000667798297740918,0.0261546033921617,0.0391529374299602
APOA2,Apolipoprotein A-II,Physical measures,X23107.Impedance of leg (right),48693,-0.0157463664297363,0.00526361967097085,-0.0260630609848392,-0.00542967187463346,0.00277904443839564
APOA2,Apolipoprotein A-II,Physical measures,X23108.Impedance of leg (left),48693,-0.0134969275946654,0.00523736874559271,-0.0237621703360271,-0.00323168485330369,0.00997200243298801
APOA2,Apolipoprotein A-II,Physical measures,X23109.Impedance of arm (right),48693,0.046773539620702,0.00644010291188953,0.0341509379133986,0.0593961413280055,3.92838964937987e-13
APOA2,Apolipoprotein A-II,Physical measures,X23110.Impedance of arm (left),48693,0.0441242008662575,0.00643236684575713,0.0315167618485735,0.0567316398839415,7.10047647578476e-12
APOA2,Apolipoprotein A-II,Physical measures,X23111.Leg fat percentage (right),48693,-0.0731593876437068,0.00836163451960065,-0.089548191302124,-0.0567705839852895,2.31082377793038e-18
APOA2,Apolipoprotein A-II,Physical measures,X23112.Leg fat mass (right),48693,-0.0695989779261516,0.00898826011219484,-0.0872159677460535,-0.0519819881062498,1.01425116306511e-14
APOA2,Apolipoprotein A-II,Physical measures,X23113.Leg fat-free mass (right),48692,0.00850278575148436,0.00871583361501145,-0.00858024813393808,0.0255858196369068,0.329296170781066
APOA2,Apolipoprotein A-II,Physical measures,X23114.Leg predicted mass (right),48692,0.0101332687110417,0.00878051046632886,-0.00707653180296285,0.0273430692250463,0.248487766480882
APOA2,Apolipoprotein A-II,Physical measures,X23115.Leg fat percentage (left),48692,-0.0801654563868555,0.00872502552800642,-0.097266506421748,-0.0630644063519629,4.38163412773215e-20
APOA2,Apolipoprotein A-II,Physical measures,X23116.Leg fat mass (left),48692,-0.0736096307886172,0.00951414098831988,-0.0922573471257242,-0.0549619144515102,1.0669138998552e-14
APOA2,Apolipoprotein A-II,Physical measures,X23117.Leg fat-free mass (left),48691,0.00155774317258726,0.0094705210105333,-0.017004478008058,0.0201199643532325,0.869352295187052
APOA2,Apolipoprotein A-II,Physical measures,X23118.Leg predicted mass (left),48691,0.00180516347979653,0.00954494327491815,-0.016902925339043,0.0205132522986361,0.849998722095299
APOA2,Apolipoprotein A-II,Physical measures,X23119.Arm fat percentage (right),48691,-0.00280802047528431,0.00923915091775782,-0.0209167562740896,0.015300715323521,0.761187227350413
APOA2,Apolipoprotein A-II,Physical measures,X23120.Arm fat mass (right),48690,-0.0316821483102527,0.0100846722391403,-0.0514481058989678,-0.0119161907215377,0.00168263267408451
APOA2,Apolipoprotein A-II,Physical measures,X23121.Arm fat-free mass (right),48689,-0.0448318900525622,0.00869500397514089,-0.0618740978438384,-0.0277896822612861,2.54603241622801e-07
APOA2,Apolipoprotein A-II,Physical measures,X23122.Arm predicted mass (right),48689,-0.0460570980112495,0.00873975393825903,-0.0631870157302371,-0.0289271802922618,1.37952845720665e-07
APOA2,Apolipoprotein A-II,Physical measures,X23123.Arm fat percentage (left),48687,0.00125026132654772,0.00869748648456278,-0.0157968121831953,0.0182973348362908,0.885699542770513
APOA2,Apolipoprotein A-II,Physical measures,X23124.Arm fat mass (left),48687,-0.033018974902181,0.00967074180095303,-0.0519736288320489,-0.0140643209723131,0.000640685324010127
APOA2,Apolipoprotein A-II,Physical measures,X23125.Arm fat-free mass (left),48683,-0.0444284861438901,0.00792525521730768,-0.0599619863698131,-0.028894985917967,2.09852077710284e-08
APOA2,Apolipoprotein A-II,Physical measures,X23126.Arm predicted mass (left),48682,-0.0433897212867446,0.00796937646375149,-0.0590096991556975,-0.0277697434177917,5.25434839679357e-08
APOA2,Apolipoprotein A-II,Physical measures,X23127.Trunk fat percentage,48681,-0.00858384985377058,0.0069684804605007,-0.022242071556352,0.00507437184881079,0.218034172632424
APOA2,Apolipoprotein A-II,Physical measures,X23128.Trunk fat mass,48681,-0.0303873365620762,0.00733166481312769,-0.0447573995958065,-0.016017273528346,3.41697305990745e-05
APOA2,Apolipoprotein A-II,Physical measures,X23129.Trunk fat-free mass,48680,-0.0259541313120248,0.0068896812693137,-0.0394579065998796,-0.0124503560241699,0.000165625221519531
APOA2,Apolipoprotein A-II,Physical measures,X23130.Trunk predicted mass,48678,-0.0247695749553739,0.00689289265953322,-0.038279644568059,-0.0112595053426888,0.000327052480903462
APOA2,Apolipoprotein A-II,NMR metabolomics,X23400.Total Cholesterol,39990,0.0159033775524295,0.00502339591081726,0.00605752156722772,0.0257492335376314,0.00155031642920994
APOA2,Apolipoprotein A-II,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,39990,-0.0207120642797369,0.00489715597532626,-0.0303104899913764,-0.0111136385680975,2.3613974305529e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",39990,-0.0416381610608336,0.0049118953935664,-0.0512654760322237,-0.0320108460894434,2.59483098791028e-17
APOA2,Apolipoprotein A-II,NMR metabolomics,X23403.VLDL Cholesterol,39990,-0.073305843674443,0.00501625148619487,-0.083137696587385,-0.0634739907615011,6.23391122627175e-48
APOA2,Apolipoprotein A-II,NMR metabolomics,X23404.Clinical LDL Cholesterol,39990,-0.00146092061878107,0.00488641985342452,-0.0110383035314931,0.008116462293931,0.764964068871619
APOA2,Apolipoprotein A-II,NMR metabolomics,X23405.LDL Cholesterol,39990,-0.00122018961162515,0.00486441738721502,-0.0107544476905666,0.00831406846731628,0.801942473567403
APOA2,Apolipoprotein A-II,NMR metabolomics,X23406.HDL Cholesterol,39990,0.132243580545182,0.005418429935097,0.121623457872392,0.142863703217973,2.79555596534487e-128
APOA2,Apolipoprotein A-II,NMR metabolomics,X23407.Total Triglycerides,39990,-0.0908422583911887,0.00506040847497641,-0.100760659002142,-0.0809238577802349,4.43212759409389e-71
APOA2,Apolipoprotein A-II,NMR metabolomics,X23408.Triglycerides in VLDL,39990,-0.0979123049875417,0.00512131286318353,-0.107950078199381,-0.0878745317757019,3.17188303917571e-80
APOA2,Apolipoprotein A-II,NMR metabolomics,X23409.Triglycerides in LDL,39990,-0.0592773270797133,0.00482747457729022,-0.0687391772512021,-0.0498154769082244,1.93476295410798e-34
APOA2,Apolipoprotein A-II,NMR metabolomics,X23410.Triglycerides in HDL,39990,-0.0467649945129078,0.00500454627563765,-0.0565739052131576,-0.036956083812658,1.09463671423591e-20
APOA2,Apolipoprotein A-II,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,39990,0.0114431902502856,0.00504975092003577,0.0015456784470155,0.0213407020535557,0.0234645530954052
APOA2,Apolipoprotein A-II,NMR metabolomics,X23412.Phospholipids in VLDL,39990,-0.0908110730079981,0.00503567819337589,-0.100681002267015,-0.0809411437489814,1.05172620511358e-71
APOA2,Apolipoprotein A-II,NMR metabolomics,X23413.Phospholipids in LDL,39990,-0.0100486318010352,0.00488128951319455,-0.0196159592468965,-0.000481304355173903,0.039555083699984
APOA2,Apolipoprotein A-II,NMR metabolomics,X23414.Phospholipids in HDL,39990,0.0850079239285151,0.00525040933516073,0.0747171216316001,0.0952987262254301,2.6196802307107e-58
APOA2,Apolipoprotein A-II,NMR metabolomics,X23415.Total Esterified Cholesterol,39990,0.0246509552683151,0.00504831375347787,0.0147562603114985,0.0345456502251317,1.05898783802099e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,39990,-0.0637962366031773,0.00500480072760395,-0.0736056460292811,-0.0539868271770736,5.79207382775178e-37
APOA2,Apolipoprotein A-II,NMR metabolomics,X23417.Cholesteryl Esters in LDL,39990,-0.00730506982613775,0.00486297382949904,-0.0168364985319559,0.00222635887968037,0.133077936528462
APOA2,Apolipoprotein A-II,NMR metabolomics,X23418.Cholesteryl Esters in HDL,39990,0.141961761184448,0.00539746176225443,0.131382736130429,0.152540786238467,4.59790357269092e-148
APOA2,Apolipoprotein A-II,NMR metabolomics,X23419.Total Free Cholesterol,39990,-0.00579274791872204,0.00496062723541862,-0.0155155773001425,0.00393008146269846,0.242934061146022
APOA2,Apolipoprotein A-II,NMR metabolomics,X23420.Free Cholesterol in VLDL,39990,-0.0831406887876089,0.00502977952921564,-0.0929990566648716,-0.0732823209103462,1.13874256282714e-60
APOA2,Apolipoprotein A-II,NMR metabolomics,X23421.Free Cholesterol in LDL,39990,0.0152141381336548,0.00488606784297333,0.00563744516142705,0.0247908311058825,0.0018516534243394
APOA2,Apolipoprotein A-II,NMR metabolomics,X23422.Free Cholesterol in HDL,39990,0.0908159924849432,0.00545868683055992,0.0801169662970458,0.101515018672841,1.99201561807361e-61
APOA2,Apolipoprotein A-II,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,39990,-0.0189583095874486,0.00484481646611128,-0.0284541498610267,-0.00946246931387047,9.16441740071211e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23424.Total Lipids in VLDL,39990,-0.0944846351996454,0.00502946248391001,-0.104342381668109,-0.0846268887311817,1.44775307537186e-77
APOA2,Apolipoprotein A-II,NMR metabolomics,X23425.Total Lipids in LDL,39990,-0.00773606226163036,0.00486659008226171,-0.0172745788228633,0.00180245429960259,0.111946695390592
APOA2,Apolipoprotein A-II,NMR metabolomics,X23426.Total Lipids in HDL,39990,0.101421045207786,0.00531942908295051,0.0909949642052027,0.111847126210369,8.39110157324935e-80
APOA2,Apolipoprotein A-II,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,39990,0.10005185431458,0.00505333553708989,0.0901473166618842,0.109956391967277,8.3238450640475e-86
APOA2,Apolipoprotein A-II,NMR metabolomics,X23428.Concentration of VLDL Particles,39990,-0.0742554450332057,0.00499883601595164,-0.0840531636244709,-0.0644577264419405,1.88507726998692e-49
APOA2,Apolipoprotein A-II,NMR metabolomics,X23429.Concentration of LDL Particles,39990,-0.0352820321108845,0.00487432669907811,-0.0448357124410776,-0.0257283517806914,4.83429350722382e-13
APOA2,Apolipoprotein A-II,NMR metabolomics,X23430.Concentration of HDL Particles,39990,0.112262100292314,0.00503060536032685,0.102402113786074,0.122122086798555,5.25525861721931e-108
APOA2,Apolipoprotein A-II,NMR metabolomics,X23431.Average Diameter for VLDL Particles,39990,-0.0945696198011907,0.00520888404646042,-0.104779032532253,-0.0843602070701282,1.22407679635088e-72
APOA2,Apolipoprotein A-II,NMR metabolomics,X23432.Average Diameter for LDL Particles,39990,0.0344606845559024,0.00502437260305068,0.0246129142539231,0.0443084548578817,7.30858830659967e-12
APOA2,Apolipoprotein A-II,NMR metabolomics,X23433.Average Diameter for HDL Particles,39990,0.0642123989863187,0.00549539272818265,0.0534414292390807,0.0749833687335567,2.30205684209879e-31
APOA2,Apolipoprotein A-II,NMR metabolomics,X23434.Phosphoglycerides,39980,0.0264267948305475,0.00504898742090757,0.0165307794855687,0.0363228101755263,1.68762217491258e-07
APOA2,Apolipoprotein A-II,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,39980,-0.126349457700323,0.00527377004648774,-0.136686046991439,-0.116012868409207,8.58087100517746e-124
APOA2,Apolipoprotein A-II,NMR metabolomics,X23436.Total Cholines,39980,0.0355773764128868,0.005134010576011,0.0255147156839052,0.0456400371418683,4.44376437652076e-12
APOA2,Apolipoprotein A-II,NMR metabolomics,X23437.Phosphatidylcholines,39980,0.0381506403849259,0.00514717804634428,0.0280621714140911,0.0482391093557607,1.33274046935584e-13
APOA2,Apolipoprotein A-II,NMR metabolomics,X23438.Sphingomyelins,39980,0.0494744526762385,0.00517438321642352,0.0393326615720484,0.0596162437804286,1.3998082832446e-21
APOA2,Apolipoprotein A-II,NMR metabolomics,X23439.Apolipoprotein B,39990,-0.0417701136978702,0.00488930711154113,-0.0513531556364908,-0.0321870717592496,1.47197207225078e-17
APOA2,Apolipoprotein A-II,NMR metabolomics,X23440.Apolipoprotein A1,39990,0.108025388294193,0.00519189136590707,0.097849281217015,0.118201495371371,2.1255967956729e-94
APOA2,Apolipoprotein A-II,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,39990,-0.0938322751248483,0.00491244267679549,-0.103460662771367,-0.0842038874783292,4.40219522343185e-80
APOA2,Apolipoprotein A-II,NMR metabolomics,X23442.Total Fatty Acids,39980,-0.0397879805797653,0.0046950579272556,-0.0489902941171862,-0.0305856670423443,2.65257111342815e-17
APOA2,Apolipoprotein A-II,NMR metabolomics,X23443.Degree of Unsaturation,39980,0.065310388390842,0.00503450925624193,0.0554427502486078,0.0751780265330762,3.26650379506462e-38
APOA2,Apolipoprotein A-II,NMR metabolomics,X23444.Omega-3 Fatty Acids,39980,-0.0141304041673393,0.00494605074376425,-0.0238246636251172,-0.00443614470956133,0.00428567243451205
APOA2,Apolipoprotein A-II,NMR metabolomics,X23445.Omega-6 Fatty Acids,39980,-0.00405905716519114,0.00488095216739953,-0.0136257234132942,0.00550760908291194,0.405645577506559
APOA2,Apolipoprotein A-II,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,39980,-0.00623485526503371,0.00490594867697476,-0.0158505146719042,0.00338080414183682,0.203798538079646
APOA2,Apolipoprotein A-II,NMR metabolomics,X23447.Monounsaturated Fatty Acids,39980,-0.0538329047217351,0.0047598308527714,-0.063162173193167,-0.0445036362503031,1.68535435457955e-29
APOA2,Apolipoprotein A-II,NMR metabolomics,X23448.Saturated Fatty Acids,39980,-0.0474610560698465,0.00462322145774272,-0.0565225701270222,-0.0383995420126708,1.28651792291808e-24
APOA2,Apolipoprotein A-II,NMR metabolomics,X23449.Linoleic Acid,39980,-0.00868700871817891,0.00486967287769692,-0.0182315675584649,0.000857550122107063,0.0744665780457226
APOA2,Apolipoprotein A-II,NMR metabolomics,X23450.Docosahexaenoic Acid,39980,0.0451210923156119,0.00489146781662996,0.0355338153950172,0.0547083692362067,3.35140420370719e-20
APOA2,Apolipoprotein A-II,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,39980,0.00817948622044497,0.00495128036112139,-0.00152502328735296,0.0178839957282429,0.098563330970322
APOA2,Apolipoprotein A-II,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,39980,0.0705533028040678,0.00480025874035865,0.0611447956729649,0.0799618099351708,1.84958432526858e-48
APOA2,Apolipoprotein A-II,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,39980,0.0754288248262033,0.00490873095138763,0.0658077121614835,0.085049937490923,9.32122029674217e-53
APOA2,Apolipoprotein A-II,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,39980,-0.0713372378586938,0.00518323033199672,-0.0814963693094073,-0.0611781064079802,9.34419118705657e-43
APOA2,Apolipoprotein A-II,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,39980,-0.0514676244460169,0.00450759426623317,-0.0603025092078339,-0.0426327396841999,4.95368756002166e-30
APOA2,Apolipoprotein A-II,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,39980,0.0525250530175671,0.00493967382037039,0.0428432923296411,0.0622068137054931,2.77075814517244e-26
APOA2,Apolipoprotein A-II,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,39980,0.0658940818897081,0.00480542882629773,0.0564754413901646,0.0753127223892517,1.8595920204059e-42
APOA2,Apolipoprotein A-II,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,39980,0.0776722570676929,0.00511227202895162,0.0676522038909478,0.0876923102444381,1.25585970282698e-51
APOA2,Apolipoprotein A-II,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,39980,0.0140110487223421,0.0048893255155228,0.00442797071191743,0.0235941267327668,0.00416929318927543
APOA2,Apolipoprotein A-II,NMR metabolomics,X23460.Alanine,39987,-0.00353616031130884,0.00489841810198991,-0.0131370597912091,0.00606473916859138,0.47037175314892
APOA2,Apolipoprotein A-II,NMR metabolomics,X23461.Glutamine,39948,0.0224190693571235,0.00479197378901076,0.0130268007306624,0.0318113379835845,2.92373757711784e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23462.Glycine,39978,0.0719680166543323,0.00577735335096713,0.0606444040864367,0.0832916292222279,2.18088154348324e-35
APOA2,Apolipoprotein A-II,NMR metabolomics,X23463.Histidine,39975,-0.0195538287348237,0.00483262749389953,-0.0290257786228668,-0.0100818788467806,5.23975537822506e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),39980,-0.0750901960382969,0.00537518944665839,-0.0856255673537474,-0.0645548247228465,5.49795362305784e-44
APOA2,Apolipoprotein A-II,NMR metabolomics,X23465.Isoleucine,39988,-0.0627919755247638,0.00519737001092974,-0.0729788207461861,-0.0526051303033415,2.11699315150266e-33
APOA2,Apolipoprotein A-II,NMR metabolomics,X23466.Leucine,39988,-0.0616953779501365,0.00532680184206886,-0.0721359095605915,-0.0512548463396815,7.562645718291e-31
APOA2,Apolipoprotein A-II,NMR metabolomics,X23467.Valine,39980,-0.079932004587462,0.00534547478957444,-0.0904091351750279,-0.0694548739998961,4.43151814794511e-50
APOA2,Apolipoprotein A-II,NMR metabolomics,X23468.Phenylalanine,39983,-0.0322295422409171,0.00493879752410434,-0.0419095853881616,-0.0225494990936726,7.05172352061437e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23469.Tyrosine,39977,-0.0509328144059751,0.00514153758233719,-0.061010228067356,-0.0408554007445942,4.85199620080108e-23
APOA2,Apolipoprotein A-II,NMR metabolomics,X23470.Glucose,39971,-0.0042256106408793,0.00472704256972949,-0.0134906140775491,0.00503939279579049,0.371382172498201
APOA2,Apolipoprotein A-II,NMR metabolomics,X23471.Lactate,39972,-0.00232952204892258,0.00497642364485708,-0.0120833123928425,0.0074242682949973,0.639713696005663
APOA2,Apolipoprotein A-II,NMR metabolomics,X23472.Pyruvate,39945,-0.000145143541753168,0.00476099724503209,-0.00947669814201605,0.00918641105850972,0.975680031725719
APOA2,Apolipoprotein A-II,NMR metabolomics,X23473.Citrate,39988,0.0144931480768403,0.00492742651811244,0.00483539210133992,0.0241509040523407,0.0032747251213504
APOA2,Apolipoprotein A-II,NMR metabolomics,X23474.3-Hydroxybutyrate,39757,0.0411822856783383,0.00545307518343204,0.0304942583188115,0.0518703130378651,4.61656661989558e-14
APOA2,Apolipoprotein A-II,NMR metabolomics,X23475.Acetate,39978,0.00199729728255482,0.00465016544773633,-0.00711702699500839,0.011111621560118,0.66755951238899
APOA2,Apolipoprotein A-II,NMR metabolomics,X23476.Acetoacetate,39989,-0.0228185518627962,0.00495821410621253,-0.0325366515109728,-0.0131004522146197,4.2262667356106e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23477.Acetone,39989,0.0134962599594457,0.00490017480668506,0.003891917338343,0.0231006025805484,0.00589218653098706
APOA2,Apolipoprotein A-II,NMR metabolomics,X23478.Creatinine,39777,0.0445480660012444,0.0060563736408436,0.0326775736651909,0.0564185583372978,2.03425963861879e-13
APOA2,Apolipoprotein A-II,NMR metabolomics,X23479.Albumin,39988,0.0101859760033098,0.00487992236870274,0.000621328160652426,0.0197506238459671,0.0368810890614108
APOA2,Apolipoprotein A-II,NMR metabolomics,X23480.Glycoprotein Acetyls,39990,-0.0186065848736153,0.0050917084201472,-0.0285863333771038,-0.0086268363701268,0.000259052353653542
APOA2,Apolipoprotein A-II,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,39990,-0.109110068323926,0.00506130366346806,-0.119030223504323,-0.0991899131435287,4.62082224973708e-101
APOA2,Apolipoprotein A-II,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,39990,-0.109372777932188,0.00502339339488703,-0.119218628986167,-0.0995269268782095,5.22187364074676e-103
APOA2,Apolipoprotein A-II,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,39990,-0.110401408208013,0.00520057570506101,-0.120594536589933,-0.100208279826094,4.07232897878689e-98
APOA2,Apolipoprotein A-II,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,39990,-0.10565410365404,0.0051211097056924,-0.115691478677197,-0.0956167286308832,7.12013449194708e-93
APOA2,Apolipoprotein A-II,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,39990,-0.107056666556751,0.00511416800320687,-0.117080435843036,-0.0970328972704655,1.65225304683236e-95
APOA2,Apolipoprotein A-II,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,39990,-0.101417131553241,0.00509519691126108,-0.111403717499312,-0.0914305456071689,1.09833142811892e-86
APOA2,Apolipoprotein A-II,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,39990,-0.109880868454733,0.00492423965402852,-0.119532378176629,-0.100229358732837,5.43177051921978e-108
APOA2,Apolipoprotein A-II,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,39990,-0.110030587334311,0.00526778657574428,-0.12035544902277,-0.0997057256458527,4.1732626474083e-95
APOA2,Apolipoprotein A-II,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,39990,-0.111586258584802,0.00522778918294539,-0.121832725383375,-0.101339791786229,3.75830577101355e-99
APOA2,Apolipoprotein A-II,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,39990,-0.114938532794012,0.0052176300992362,-0.125165087788515,-0.104711977799509,2.36988697890294e-105
APOA2,Apolipoprotein A-II,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,39990,-0.106348516854686,0.00520583490295375,-0.116551953264476,-0.0961450804448968,3.95036816818083e-91
APOA2,Apolipoprotein A-II,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,39990,-0.0962002199525256,0.00522136247602005,-0.106434090405525,-0.0859663494995263,1.01537112990574e-74
APOA2,Apolipoprotein A-II,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,39990,-0.112690147789408,0.00517925052500922,-0.122841478818426,-0.10253881676039,7.10194464169458e-103
APOA2,Apolipoprotein A-II,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,39990,-0.109351041647943,0.00524601341457253,-0.119633227940505,-0.0990688553553809,9.89208239430262e-95
APOA2,Apolipoprotein A-II,NMR metabolomics,X23495.Concentration of Large VLDL Particles,39990,-0.101433054950253,0.0052020723399266,-0.111629116736509,-0.0912369931639965,2.5564030152349e-83
APOA2,Apolipoprotein A-II,NMR metabolomics,X23496.Total Lipids in Large VLDL,39990,-0.100387870501149,0.00518673835377451,-0.110553877674547,-0.0902218633277509,3.85102193166349e-82
APOA2,Apolipoprotein A-II,NMR metabolomics,X23497.Phospholipids in Large VLDL,39990,-0.105687385561966,0.00528565500230062,-0.116047269366476,-0.0953275017574571,1.9042549962911e-87
APOA2,Apolipoprotein A-II,NMR metabolomics,X23498.Cholesterol in Large VLDL,39990,-0.0955556060916281,0.00524053295001732,-0.105827050673662,-0.0852841615095941,3.04239979203115e-73
APOA2,Apolipoprotein A-II,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,39990,-0.0851624507928418,0.00521961125769242,-0.0953928888579189,-0.0749320127277647,3.56218632685002e-59
APOA2,Apolipoprotein A-II,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,39990,-0.103199856263311,0.00527405971701329,-0.113537013308657,-0.0928626992179652,6.93392898240209e-84
APOA2,Apolipoprotein A-II,NMR metabolomics,X23501.Triglycerides in Large VLDL,39990,-0.0974825039852829,0.00511168530810282,-0.107501407189164,-0.0874636007814013,7.73857560528299e-80
APOA2,Apolipoprotein A-II,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,39990,-0.0593864749541865,0.00497021671030505,-0.0691280997063844,-0.0496448502019886,1.03704153140916e-32
APOA2,Apolipoprotein A-II,NMR metabolomics,X23503.Total Lipids in Medium VLDL,39990,-0.0671316721545906,0.00497136462998091,-0.0768755468293532,-0.057387797479828,3.0873619031834e-41
APOA2,Apolipoprotein A-II,NMR metabolomics,X23504.Phospholipids in Medium VLDL,39990,-0.0584091517539463,0.00496152397697628,-0.0681337387488198,-0.0486845647590728,8.27587573018228e-32
APOA2,Apolipoprotein A-II,NMR metabolomics,X23505.Cholesterol in Medium VLDL,39990,-0.0252203911041964,0.0049065721049746,-0.0348372724299466,-0.0156035097784462,2.7910758514485e-07
APOA2,Apolipoprotein A-II,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,39990,-0.00675893740679872,0.00489751217010246,-0.0163580612601995,0.00284018644660209,0.167590433177268
APOA2,Apolipoprotein A-II,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,39990,-0.0470874705804314,0.00494856431465966,-0.0567866566371643,-0.0373882845236984,2.17391473475144e-21
APOA2,Apolipoprotein A-II,NMR metabolomics,X23508.Triglycerides in Medium VLDL,39990,-0.0809077982152811,0.00507869550556633,-0.0908620414061911,-0.0709535550243711,1.57670686811865e-56
APOA2,Apolipoprotein A-II,NMR metabolomics,X23509.Concentration of Small VLDL Particles,39990,-0.0647198964700773,0.00512215234565645,-0.0747593150675639,-0.0546804778725907,2.36435121300247e-36
APOA2,Apolipoprotein A-II,NMR metabolomics,X23510.Total Lipids in Small VLDL,39990,-0.0643237382620877,0.00512888224430981,-0.0743763474609349,-0.0542711290632404,7.63391297759e-36
APOA2,Apolipoprotein A-II,NMR metabolomics,X23511.Phospholipids in Small VLDL,39990,-0.0506972367101305,0.00504809593822422,-0.06059150474905,-0.040802968671211,1.23878211974706e-23
APOA2,Apolipoprotein A-II,NMR metabolomics,X23512.Cholesterol in Small VLDL,39990,-0.0483845335741989,0.00509748840314285,-0.0583756108443589,-0.0383934563040389,2.72076021257562e-21
APOA2,Apolipoprotein A-II,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,39990,-0.0559047016134704,0.00518056440282238,-0.0660586078430023,-0.0457507953839385,5.1148875314735e-27
APOA2,Apolipoprotein A-II,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,39990,-0.0350452062041707,0.00496801618119293,-0.0447825179193088,-0.0253078944890325,1.83706241523328e-12
APOA2,Apolipoprotein A-II,NMR metabolomics,X23515.Triglycerides in Small VLDL,39990,-0.0687232241965323,0.00516503273623257,-0.0788466883595481,-0.0585997600335164,4.28264824235658e-40
APOA2,Apolipoprotein A-II,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,39990,-0.059594735109145,0.00492161685515285,-0.0692411041452446,-0.0499483660730454,1.52490159735099e-33
APOA2,Apolipoprotein A-II,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,39990,-0.0617548334382696,0.00494989797984888,-0.0714566334787734,-0.0520530333977658,1.72156691367505e-35
APOA2,Apolipoprotein A-II,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,39990,-0.0714166674346993,0.00491669830925293,-0.0810533961208351,-0.0617799387485636,2.21849912372537e-47
APOA2,Apolipoprotein A-II,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,39990,-0.0421574136624291,0.00500544024497178,-0.0519680765425738,-0.0323467507822844,4.13291576865262e-17
APOA2,Apolipoprotein A-II,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,39990,-0.035844295590538,0.00504584391952597,-0.0457341496728089,-0.0259544415082671,1.28678350752863e-12
APOA2,Apolipoprotein A-II,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,39990,-0.054974727734453,0.00494544956624,-0.0646678088842834,-0.0452816465846226,1.46690063996272e-28
APOA2,Apolipoprotein A-II,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,39990,-0.0647614548350413,0.00502544654372323,-0.0746113300607388,-0.0549115796093438,9.81021870561755e-38
APOA2,Apolipoprotein A-II,NMR metabolomics,X23523.Concentration of IDL Particles,39990,-0.0399708647113452,0.00490162167610302,-0.0495780431965072,-0.0303636862261833,3.86951719266475e-16
APOA2,Apolipoprotein A-II,NMR metabolomics,X23524.Total Lipids in IDL,39990,-0.0101862041258378,0.0050315144749287,-0.020047972496698,-0.000324435754977499,0.0429440012020429
APOA2,Apolipoprotein A-II,NMR metabolomics,X23525.Phospholipids in IDL,39990,-0.0148629584959724,0.00502531572855045,-0.0247125773239313,-0.0050133396680135,0.00310663905906325
APOA2,Apolipoprotein A-II,NMR metabolomics,X23526.Cholesterol in IDL,39990,-0.000427176300960661,0.00505541602082618,-0.01033579170178,0.00948143909985866,0.932661386967567
APOA2,Apolipoprotein A-II,NMR metabolomics,X23527.Cholesteryl Esters in IDL,39990,-0.00196283773681046,0.00506287256686889,-0.0118860679678735,0.00796039249425257,0.698250849179096
APOA2,Apolipoprotein A-II,NMR metabolomics,X23528.Free Cholesterol in IDL,39990,0.00377073931163744,0.0050143706253815,-0.00605742711411029,0.0135989057373852,0.452074680594551
APOA2,Apolipoprotein A-II,NMR metabolomics,X23529.Triglycerides in IDL,39990,-0.0623671232936876,0.00486435614695613,-0.0719012613417216,-0.0528329852456536,2.25952162173714e-37
APOA2,Apolipoprotein A-II,NMR metabolomics,X23530.Concentration of Large LDL Particles,39990,-0.0307041281198789,0.0048582171955835,-0.0402262338232225,-0.0211820224165352,2.71261901170787e-10
APOA2,Apolipoprotein A-II,NMR metabolomics,X23531.Total Lipids in Large LDL,39990,0.00334456963541995,0.00489341754331824,-0.00624652874948381,0.0129356680203237,0.494315342371589
APOA2,Apolipoprotein A-II,NMR metabolomics,X23532.Phospholipids in Large LDL,39990,0.002001208048064,0.00490725627547378,-0.0076170142518646,0.0116194303479926,0.683423848636275
APOA2,Apolipoprotein A-II,NMR metabolomics,X23533.Cholesterol in Large LDL,39990,0.00936743407059249,0.00489343415711172,-0.000223696877346472,0.0189585650185315,0.0556086103100436
APOA2,Apolipoprotein A-II,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,39990,0.00604939395146071,0.00488608256644967,-0.00352732787878064,0.0156261157817021,0.215709424775388
APOA2,Apolipoprotein A-II,NMR metabolomics,X23535.Free Cholesterol in Large LDL,39990,0.018405226598125,0.00493212757896613,0.00873825654335137,0.0280721966528986,0.000191115685428549
APOA2,Apolipoprotein A-II,NMR metabolomics,X23536.Triglycerides in Large LDL,39990,-0.0553054826738164,0.00482640345439591,-0.0647652334444324,-0.0458457319032004,3.10524013470838e-30
APOA2,Apolipoprotein A-II,NMR metabolomics,X23537.Concentration of Medium LDL Particles,39990,-0.0346240890513617,0.00490004780718042,-0.0442281827534353,-0.025019995349288,1.68683595851293e-12
APOA2,Apolipoprotein A-II,NMR metabolomics,X23538.Total Lipids in Medium LDL,39990,-0.0205401094166147,0.00487987507420911,-0.0301046645620646,-0.0109755542711648,2.58304176263345e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23539.Phospholipids in Medium LDL,39990,-0.0191958264977701,0.00489836343171962,-0.0287966188239405,-0.0095950341715996,8.95022829297595e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23540.Cholesterol in Medium LDL,39990,-0.0162327037274156,0.00487249946862024,-0.0257828026859113,-0.00668260476891994,0.000866559343769515
APOA2,Apolipoprotein A-II,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,39990,-0.0265039981463065,0.00488621398654227,-0.0360809775599294,-0.0169270187326837,5.93916388903283e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,39990,0.0122617811053354,0.00484921487435238,0.00275731995160477,0.0217662422590661,0.0114648570664384
APOA2,Apolipoprotein A-II,NMR metabolomics,X23543.Triglycerides in Medium LDL,39990,-0.0575157220094018,0.00485416236035953,-0.0670298802357065,-0.0480015637830971,3.37554175195952e-32
APOA2,Apolipoprotein A-II,NMR metabolomics,X23544.Concentration of Small LDL Particles,39990,-0.0515969186910252,0.00489207580757317,-0.0611853872738687,-0.0420084501081818,6.89946368512453e-26
APOA2,Apolipoprotein A-II,NMR metabolomics,X23545.Total Lipids in Small LDL,39990,-0.0380151120958907,0.00483666642706548,-0.047494978292939,-0.0285352458988423,4.19443969675457e-15
APOA2,Apolipoprotein A-II,NMR metabolomics,X23546.Phospholipids in Small LDL,39990,-0.0401823877650262,0.00482070713834571,-0.0496309737561838,-0.0307338017738686,8.61125823324738e-17
APOA2,Apolipoprotein A-II,NMR metabolomics,X23547.Cholesterol in Small LDL,39990,-0.0283689781402635,0.00485450990315757,-0.0378838175504523,-0.0188541387300746,5.24085292685655e-09
APOA2,Apolipoprotein A-II,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,39990,-0.0393796265359531,0.00485204672170809,-0.0488896381105009,-0.0298696149614052,5.30892737284074e-16
APOA2,Apolipoprotein A-II,NMR metabolomics,X23549.Free Cholesterol in Small LDL,39990,0.00293820340490044,0.00485438097095503,-0.00657638329817142,0.0124527901079723,0.545012732945549
APOA2,Apolipoprotein A-II,NMR metabolomics,X23550.Triglycerides in Small LDL,39990,-0.07693365775937,0.00487989943380634,-0.0864982606496304,-0.0673690548691096,2.07025118279311e-55
APOA2,Apolipoprotein A-II,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,39990,0.0121922727481737,0.00562312418984925,0.00117094933606916,0.0232135961602782,0.030161201763425
APOA2,Apolipoprotein A-II,NMR metabolomics,X23552.Total Lipids in Very Large HDL,39990,0.00824378048093045,0.00563937287219547,-0.00280939034857268,0.0192969513104336,0.143816553733484
APOA2,Apolipoprotein A-II,NMR metabolomics,X23553.Phospholipids in Very Large HDL,39990,0.00408687647152896,0.00560683290767727,-0.00690251602751849,0.0150762689705764,0.466071715583691
APOA2,Apolipoprotein A-II,NMR metabolomics,X23554.Cholesterol in Very Large HDL,39990,0.0229406448608646,0.0057095438597475,0.0117499388957595,0.0341313508259697,5.90848368815573e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,39990,0.0401149304201372,0.00573543695186245,0.0288734739944868,0.0513563868457876,2.81671535917462e-12
APOA2,Apolipoprotein A-II,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,39990,-0.0315826673804873,0.00553731524962149,-0.0424358052697454,-0.0207295294912291,1.20219100920834e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23557.Triglycerides in Very Large HDL,39990,-0.0467137157028981,0.00467832382472204,-0.0558832303993533,-0.0375442010064429,2.20898823797285e-23
APOA2,Apolipoprotein A-II,NMR metabolomics,X23558.Concentration of Large HDL Particles,39990,0.0970040197070816,0.00562050501612115,0.0859878298754841,0.108020209538679,6.58333557229427e-66
APOA2,Apolipoprotein A-II,NMR metabolomics,X23559.Total Lipids in Large HDL,39990,0.089501872640906,0.00558209904893755,0.0785609585049884,0.100442786776824,3.13631711841242e-57
APOA2,Apolipoprotein A-II,NMR metabolomics,X23560.Phospholipids in Large HDL,39990,0.0843795196003345,0.00552941631615005,0.0735418636206804,0.0952171755799886,4.60898237902436e-52
APOA2,Apolipoprotein A-II,NMR metabolomics,X23561.Cholesterol in Large HDL,39990,0.0991550206246689,0.00565765106450628,0.0880660245382366,0.110244016711101,7.05204916487375e-68
APOA2,Apolipoprotein A-II,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,39990,0.108813897353779,0.00566285882363777,0.097714694059449,0.119913100648109,5.23420041915647e-81
APOA2,Apolipoprotein A-II,NMR metabolomics,X23563.Free Cholesterol in Large HDL,39990,0.0664182045703567,0.00562489157789084,0.0553934170776907,0.0774429920630228,5.45788675421546e-32
APOA2,Apolipoprotein A-II,NMR metabolomics,X23564.Triglycerides in Large HDL,39990,-0.00669558802384453,0.00493489068196226,-0.0163679737604906,0.00297679771280151,0.174876271044232
APOA2,Apolipoprotein A-II,NMR metabolomics,X23565.Concentration of Medium HDL Particles,39990,0.109627538858108,0.00512408514722603,0.0995843319695446,0.119670745746671,1.34982418993029e-99
APOA2,Apolipoprotein A-II,NMR metabolomics,X23566.Total Lipids in Medium HDL,39990,0.0964206869708596,0.00505746853547091,0.0865080486413366,0.106333325300383,8.5706167915559e-80
APOA2,Apolipoprotein A-II,NMR metabolomics,X23567.Phospholipids in Medium HDL,39990,0.0774208438677604,0.00499514660400157,0.0676303565239174,0.0872113312116035,1.23741644880562e-53
APOA2,Apolipoprotein A-II,NMR metabolomics,X23568.Cholesterol in Medium HDL,39990,0.127518489944411,0.00514981556222241,0.117424851442456,0.137612128446367,6.85769103738235e-132
APOA2,Apolipoprotein A-II,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,39990,0.132348427309143,0.00512903061221394,0.122295527309204,0.142401327309083,9.67898026646968e-143
APOA2,Apolipoprotein A-II,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,39990,0.103578593422917,0.00522592009454904,0.0933357900376009,0.113821396808233,5.56273990387994e-86
APOA2,Apolipoprotein A-II,NMR metabolomics,X23571.Triglycerides in Medium HDL,39990,-0.0463161063916309,0.00505916990483868,-0.0562320794051147,-0.0364001333781471,6.36722694858439e-20
APOA2,Apolipoprotein A-II,NMR metabolomics,X23572.Concentration of Small HDL Particles,39990,0.0767079273846222,0.00483956227345023,0.0672223853286597,0.0861934694405846,5.55081177398683e-56
APOA2,Apolipoprotein A-II,NMR metabolomics,X23573.Total Lipids in Small HDL,39990,0.0546745936633424,0.00486771381175412,0.0451338745923043,0.0642153127343805,4.034950549983e-29
APOA2,Apolipoprotein A-II,NMR metabolomics,X23574.Phospholipids in Small HDL,39990,0.0472797866240599,0.00484965057650636,0.0377744714941074,0.0567851017540123,2.27589104959068e-22
APOA2,Apolipoprotein A-II,NMR metabolomics,X23575.Cholesterol in Small HDL,39990,0.0870873637941105,0.00479798177392435,0.0776833195172187,0.0964914080710022,1.32823234149278e-72
APOA2,Apolipoprotein A-II,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,39990,0.0934220869413475,0.00480684303906621,0.0840006745847777,0.102843499297917,8.46057540025209e-83
APOA2,Apolipoprotein A-II,NMR metabolomics,X23577.Free Cholesterol in Small HDL,39990,0.0586877344217405,0.0048320342721085,0.0492169472484079,0.0681585215950732,9.78821562717666e-34
APOA2,Apolipoprotein A-II,NMR metabolomics,X23578.Triglycerides in Small HDL,39990,-0.0777236868075125,0.00541805195003277,-0.0883430686295768,-0.0671043049854483,2.88118758651948e-46
APOA2,Apolipoprotein A-II,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39655,0.0516943679589331,0.0054667688883258,0.0409795009378145,0.0624092349800516,3.84122511820648e-21
APOA2,Apolipoprotein A-II,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39655,0.0780585574530179,0.00521782827535659,0.0678316140333189,0.0882855008727168,4.14092464272243e-50
APOA2,Apolipoprotein A-II,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39655,0.0564520647450888,0.00530251817642378,0.0460591291192982,0.0668450003708795,2.43420183980041e-26
APOA2,Apolipoprotein A-II,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39655,0.101472430933642,0.00516525148835499,0.0913485380164659,0.111596323850817,1.73828638421057e-84
APOA2,Apolipoprotein A-II,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39655,-0.0772043024184895,0.00529130432355254,-0.0875752588926525,-0.0668333459443266,8.92792118155303e-48
APOA2,Apolipoprotein A-II,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39927,-0.0601477030642598,0.00532768922477615,-0.070589973944821,-0.0497054321836985,2.11920384847079e-29
APOA2,Apolipoprotein A-II,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39927,0.0651085679342059,0.00539428052532863,0.0545357781045617,0.07568135776385,2.43832086440579e-33
APOA2,Apolipoprotein A-II,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39927,0.0737683163381201,0.00535402668452708,0.063274424036447,0.0842622086397932,7.64438044383471e-43
APOA2,Apolipoprotein A-II,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39927,0.0171010335423148,0.00543205488980475,0.00645420595829748,0.0277478611263321,0.00164722426410994
APOA2,Apolipoprotein A-II,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39927,-0.0384364840083853,0.00540253359080142,-0.0490254498463561,-0.0278475181704145,1.19071220298532e-12
APOA2,Apolipoprotein A-II,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,39990,-0.0802541615411792,0.00556869816358492,-0.0911688099418057,-0.0693395131405528,1.12401131926719e-46
APOA2,Apolipoprotein A-II,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,39990,0.0422024624261901,0.00523920322265868,0.0319336241097791,0.0524713007426011,8.72962222922439e-16
APOA2,Apolipoprotein A-II,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,39990,0.0564410514803558,0.00531057866989358,0.0460323172873644,0.0668497856733472,2.92925059552191e-26
APOA2,Apolipoprotein A-II,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,39990,-0.00253929237988138,0.00533186698919438,-0.0129897516787024,0.00791116691893961,0.633906656039397
APOA2,Apolipoprotein A-II,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,39990,-0.00607189242943317,0.00535642249940463,-0.0165704805282662,0.00442669566939991,0.256997836363339
APOA2,Apolipoprotein A-II,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,39990,0.0184565930932463,0.00516486527374998,0.00833345715669636,0.0285797290297963,0.000353710588684752
APOA2,Apolipoprotein A-II,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,39990,0.0531251932783392,0.00532289854703803,0.0426923121261447,0.0635580744305338,2.31380002113075e-23
APOA2,Apolipoprotein A-II,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,39990,0.0576367631937523,0.00534820609370734,0.0471542792500859,0.0681192471374186,5.97238762796962e-27
APOA2,Apolipoprotein A-II,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,39990,0.0402568103082425,0.00521975949316108,0.0300260817016467,0.0504875389148382,1.3376590603211e-14
APOA2,Apolipoprotein A-II,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,39990,-0.0457151260173131,0.0052839380874841,-0.0560716446687819,-0.0353586073658443,5.75260798685949e-18
APOA2,Apolipoprotein A-II,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,39990,0.0392759595725971,0.00520415422708243,0.0290758172875156,0.0494761018576787,4.79195558705093e-14
APOA2,Apolipoprotein A-II,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,39990,0.0205850281494258,0.00503603232304099,0.0107144047962655,0.0304556515025862,4.38946838716372e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,39990,0.00374192643336598,0.00496051491038784,-0.00598068279099418,0.0134645356577261,0.450659278762303
APOA2,Apolipoprotein A-II,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,39990,0.0435895971350859,0.00524626427820567,0.0333069191498028,0.053872275120369,1.07709886839053e-16
APOA2,Apolipoprotein A-II,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,39990,-0.0263929080883675,0.00508451181051364,-0.0363585512369742,-0.0164272649397608,2.12948102102096e-07
APOA2,Apolipoprotein A-II,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,39990,-0.0907800536604411,0.00485887953562934,-0.100303457550275,-0.0812566497706076,9.44475284378003e-77
APOA2,Apolipoprotein A-II,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,39990,0.0340507425864151,0.00519171081562646,0.0238749893877873,0.044226495785043,5.66381745895077e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,39990,0.0362859605315742,0.00525830332562522,0.0259796860133488,0.0465922350497996,5.44936286187008e-12
APOA2,Apolipoprotein A-II,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,39990,0.0106254213137039,0.00459751644390102,0.00161428908365793,0.0196365535437499,0.0208438832765785
APOA2,Apolipoprotein A-II,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,39990,-0.0153908372647809,0.00513564808457752,-0.0254567075105528,-0.00532496701900895,0.00273360429429338
APOA2,Apolipoprotein A-II,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,39990,-0.0241078907791014,0.00481870968115536,-0.0335525617541659,-0.0146632198040369,5.7294229806036e-07
APOA2,Apolipoprotein A-II,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,39990,0.0481514785976933,0.00502832763831082,0.0382959564266041,0.0580070007687825,1.21639179361018e-21
APOA2,Apolipoprotein A-II,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,39990,0.0343061334435042,0.00497666412099795,0.0245518717663482,0.0440603951206602,5.73528791221527e-12
APOA2,Apolipoprotein A-II,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,39990,0.0497741662101887,0.00462025272805667,0.0407184708631977,0.0588298615571798,6.22160724931179e-27
APOA2,Apolipoprotein A-II,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,39990,-0.04835398686193,0.00506863670096594,-0.0582885147958232,-0.0384194589280367,1.72086630325033e-21
APOA2,Apolipoprotein A-II,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,39990,-0.0108528206153964,0.00492232826176578,-0.0205005840084573,-0.00120505722233547,0.027487029715805
APOA2,Apolipoprotein A-II,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,39990,0.0706493719035076,0.00498672147612917,0.0608753978102945,0.0804233459967208,3.51974741264547e-45
APOA2,Apolipoprotein A-II,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,39990,0.0359965592283779,0.00478179201081308,0.0266242468871842,0.0453688715695715,5.54779097376004e-14
APOA2,Apolipoprotein A-II,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,39990,0.0667422637807802,0.00534920079971387,0.056257830213341,0.0772266973482193,1.69885248568862e-35
APOA2,Apolipoprotein A-II,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,39990,-0.0577374986135873,0.00491807840443718,-0.0673769322862842,-0.0480980649408904,1.2114197690017e-31
APOA2,Apolipoprotein A-II,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,39990,0.0180388687846028,0.00505048824782399,0.00813991181886775,0.0279378257503378,0.000356123595980629
APOA2,Apolipoprotein A-II,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,39990,0.0390532786717222,0.00498056655257956,0.0292913682286663,0.0488151891147782,4.86284698371846e-15
APOA2,Apolipoprotein A-II,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,39990,-0.0617434821209484,0.00501592174181181,-0.0715746887348995,-0.0519122755069972,1.33570318050851e-34
APOA2,Apolipoprotein A-II,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,39990,0.0942207354704886,0.00511748378202679,0.0841904672577161,0.104251003683261,1.27781012425367e-74
APOA2,Apolipoprotein A-II,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,39990,-0.0435984179729257,0.00491217915240452,-0.0532262891116386,-0.0339705468342128,7.99482923439839e-19
APOA2,Apolipoprotein A-II,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,39990,0.00328792075718184,0.00503773937925403,-0.00658604842615606,0.0131618899405197,0.513989975998127
APOA2,Apolipoprotein A-II,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,39990,0.0565860101887962,0.00487323911785131,0.0470344615178077,0.0661375588597848,5.37847235676557e-31
APOA2,Apolipoprotein A-II,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,39990,-0.0292854581993679,0.00498747226800434,-0.0390609038446564,-0.0195100125540794,4.43112592710012e-09
APOA2,Apolipoprotein A-II,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,39990,0.0776754837217798,0.00488731767519191,0.0680963410784036,0.0872546263651559,2.83516182233853e-56
APOA2,Apolipoprotein A-II,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,39990,-0.0585351945796218,0.00500482745115871,-0.0683446563838929,-0.0487257327753507,2.02604582886541e-31
APOA2,Apolipoprotein A-II,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,39978,-0.00939865057450446,0.00532911075750946,-0.019843707659223,0.00104640651021408,0.0778188842537863
APOA2,Apolipoprotein A-II,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,39978,0.0413017857969488,0.00461203204743644,0.0322622029839733,0.0503413686099242,3.91611319606442e-19
APOA2,Apolipoprotein A-II,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,39978,0.0897577507420326,0.0042430134315929,0.0814414444161106,0.0980740570679547,1.872258173222e-97
APOA2,Apolipoprotein A-II,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,39978,-0.0678875227004712,0.00550238500444588,-0.0786721973091851,-0.0571028480917573,9.44716884954388e-35
APOA2,Apolipoprotein A-II,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,39978,-0.0416438871733449,0.0052276389882092,-0.0518900595902349,-0.0313977147564549,1.7934885227418e-15
APOA2,Apolipoprotein A-II,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,39990,-0.0588746575659216,0.00493203900437562,-0.0685414540144978,-0.0492078611173454,1.18576302093727e-32
APOA2,Apolipoprotein A-II,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,39990,0.0820468577927863,0.00518501891276623,0.0718842207237645,0.0922094948618081,8.3633124373109e-56
APOA2,Apolipoprotein A-II,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,39990,0.0966267755682398,0.00495868437649019,0.086907754190319,0.106345796946161,3.22061572762268e-83
APOA2,Apolipoprotein A-II,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,39990,-0.0417278155663887,0.00497974195721049,-0.0514881098025212,-0.0319675213302561,5.93757342271594e-17
APOA2,Apolipoprotein A-II,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,39990,-0.0740009312576173,0.00498703325807584,-0.083775516443446,-0.0642263460717887,2.37805358031024e-49
APOA2,Apolipoprotein A-II,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,39990,-0.173038853000333,0.00511862910909055,-0.18307136605415,-0.163006339946515,8.07075001462089e-239
APOA2,Apolipoprotein A-II,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,39990,0.146846993094757,0.00516674476562547,0.136720173354131,0.156973812835383,9.88478110197996e-172
APOA2,Apolipoprotein A-II,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,39990,0.131407209581802,0.00492123924001815,0.121761580671366,0.141052838492238,2.06433971623319e-152
APOA2,Apolipoprotein A-II,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,39990,0.0979680023107991,0.00553562309800342,0.0871181810387124,0.108817823582886,3.66601669200466e-69
APOA2,Apolipoprotein A-II,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,39990,-0.116271447546281,0.00514891748040402,-0.126363325807873,-0.106179569284689,1.71055857716444e-110
APOA2,Apolipoprotein A-II,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,39990,-0.0332992487775169,0.00486203603407628,-0.0428288394043064,-0.0237696581507274,7.82903337467081e-12
APOA2,Apolipoprotein A-II,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,39990,0.0891454279959475,0.00476118267388068,0.0798135099551413,0.0984773460367536,4.55705389586488e-77
APOA2,Apolipoprotein A-II,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,39990,0.0827535998844281,0.0046940395773526,0.073553282312817,0.0919539174560392,1.18925493393024e-68
APOA2,Apolipoprotein A-II,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,39990,0.0201957990172062,0.00519309681452912,0.0100173292607292,0.0303742687736833,0.000101242419976599
APOA2,Apolipoprotein A-II,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,39990,-0.123537486139304,0.00534999399867794,-0.134023474376713,-0.113051497901895,2.47090650479939e-115
APOA2,Apolipoprotein A-II,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,48865,0.00647592596140124,0.00409453317437285,-0.00154935906036956,0.014501210983172,0.113755834205026
APOA2,Apolipoprotein A-II,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,48865,0.00629023539904544,0.0039913825716999,-0.00153287444148635,0.0141133452395772,0.115052010338779
APOA2,Apolipoprotein A-II,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,47445,0.00742379690264277,0.00381206833675609,-4.78570373991741e-05,0.0148954508426847,0.0514961296008446
APOA2,Apolipoprotein A-II,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,47445,0.00365003620052941,0.00415393443839653,-0.0044916752987278,0.0117917476997866,0.379578555332603
APOA2,Apolipoprotein A-II,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,47445,0.00560805226905464,0.00409641380162665,-0.0024209187821336,0.0136370233202429,0.17101087754767
APOA2,Apolipoprotein A-II,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,47445,0.00480034052658277,0.00378395909011135,-0.00261621929003547,0.012216900343201,0.204598488979859
APOA2,Apolipoprotein A-II,Working and living environment,X24009.Traffic intensity on the nearest road,48865,0.0499969393225962,0.0559537524336053,-0.0596724154472701,0.159666294092463,0.371578449249237
APOA2,Apolipoprotein A-II,Working and living environment,X24010.Inverse distance to the nearest road,48865,0.0013796237952623,0.00359330183741183,-0.00566324780606488,0.00842249539658948,0.701024577041963
APOA2,Apolipoprotein A-II,Working and living environment,X24011.Traffic intensity on the nearest major road,48865,-0.00118479756951979,0.00356561767649993,-0.00817340821545965,0.00580381307642007,0.739678285582054
APOA2,Apolipoprotein A-II,Working and living environment,X24012.Inverse distance to the nearest major road,48865,0.00342937113384333,0.00364341949440657,-0.00371173107519354,0.0105704733428802,0.346587622443252
APOA2,Apolipoprotein A-II,Working and living environment,X24013.Total traffic load on major roads,48865,0.0736181990624628,0.0389776293381265,-0.0027779544402651,0.150014352565191,0.058942349171304
APOA2,Apolipoprotein A-II,Working and living environment,X24015.Sum of road length of major roads within 100m,48865,0.102779489734147,0.0380120419308083,0.0282758875497632,0.177283091918532,0.00685949940120718
APOA2,Apolipoprotein A-II,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,48865,0.00858699328891868,0.00411590056729787,0.000519828177014858,0.0166541584008225,0.0369641498513411
APOA2,Apolipoprotein A-II,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,48865,0.00757762931049441,0.00411546860896905,-0.000488689163084932,0.0156439477840737,0.0655987290392867
APOA2,Apolipoprotein A-II,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,48865,0.0069270752739313,0.00406509760115005,-0.0010405160243228,0.0148946665721854,0.088389571940245
APOA2,Apolipoprotein A-II,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,48826,0.00119212499897815,0.0039642091922065,-0.00657772501774658,0.00896197501570289,0.763629566441352
APOA2,Apolipoprotein A-II,Working and living environment,X24020.Average daytime sound level of noise pollution,48865,0.000279436511735066,0.00357724994676709,-0.00673197338392842,0.00729084640739855,0.937737428403988
APOA2,Apolipoprotein A-II,Working and living environment,X24021.Average evening sound level of noise pollution,48865,0.000271206013563965,0.00357783512670328,-0.00674135083477447,0.0072837628619024,0.939577605501603
APOA2,Apolipoprotein A-II,Working and living environment,X24022.Average night-time sound level of noise pollution,48865,0.000260515045641619,0.00357725787893812,-0.0067509103970771,0.00727194048836034,0.941945819392464
APOA2,Apolipoprotein A-II,Working and living environment,X24023.Average 16-hour sound level of noise pollution,48865,0.000324766070575787,0.00357766295179899,-0.00668745331495024,0.00733698545610181,0.927671446947182
APOA2,Apolipoprotein A-II,Working and living environment,X24024.Average 24-hour sound level of noise pollution,48865,0.000305510341490278,0.00357773817298964,-0.00670685647756941,0.00731787716054997,0.931950569151908
APOA2,Apolipoprotein A-II,Health and medical history,X2405.Number of children fathered,48855,-0.114844904547065,0.0294043251254567,-0.17247738179296,-0.0572124273011696,9.42521255332744e-05
APOA2,Apolipoprotein A-II,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",46543,-0.00448860519861223,0.00423999430732328,-0.0127989940409659,0.00382178364374141,0.289780418011181
APOA2,Apolipoprotein A-II,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",46543,0.00390834693294181,0.00381036147955559,-0.00355996156698715,0.0113766554328708,0.305039520853321
APOA2,Apolipoprotein A-II,Working and living environment,"X24502.Water percentage, buffer 1000m",46543,-0.00211688014198288,0.00384175855448465,-0.0096467269087728,0.00541296662480704,0.581627834486139
APOA2,Apolipoprotein A-II,Working and living environment,"X24503.Greenspace percentage, buffer 300m",46543,-0.00130688456326729,0.00397676590405823,-0.00910134573522142,0.00648757660868683,0.742439207782209
APOA2,Apolipoprotein A-II,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",46543,-0.00043897208480834,0.0038523679574566,-0.00798961328142327,0.00711166911180659,0.909279783360898
APOA2,Apolipoprotein A-II,Working and living environment,"X24505.Water percentage, buffer 300m",46543,0.00252801719804846,0.00387036147675233,-0.0050578912963861,0.010113925692483,0.513652860344413
APOA2,Apolipoprotein A-II,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",48934,-0.00251440868816013,0.00405311780605187,-0.0104585195880218,0.00542970221170153,0.53502506953035
APOA2,Apolipoprotein A-II,Working and living environment,"X24507.Natural environment percentage, buffer 300m",48934,-0.00167834562209686,0.00379952054649168,-0.00912540589322055,0.00576871464902683,0.658692455114329
APOA2,Apolipoprotein A-II,Working and living environment,X24508.Distance (Euclidean) to coast,48934,0.0051151080799036,0.00359058764913922,-0.00192244371240926,0.0121526598722165,0.154291677398325
APOA2,Apolipoprotein A-II,Lifestyle factors,X2867.Age started smoking in former smokers,34621,-0.00540688043771306,0.00675134922278843,-0.0186395249143784,0.00782576403895226,0.423244736591764
APOA2,Apolipoprotein A-II,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35746,-0.0537750617782508,0.0610545591662057,-0.173441997744014,0.0658918741875125,0.378471615122916
APOA2,Apolipoprotein A-II,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35748,-0.035515435922504,0.0693572822257463,-0.171455709084967,0.100424837239959,0.608621351331575
APOA2,Apolipoprotein A-II,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35748,-0.0621794154705142,0.064492372650858,-0.188584465866196,0.0642256349251676,0.335010391927454
APOA2,Apolipoprotein A-II,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35738,-0.0141614495354703,0.0653247370009732,-0.142197934057378,0.113875034986437,0.828381784082614
APOA2,Apolipoprotein A-II,Mental health,X28739.Difficulty with standing for long periods,35749,0.0372447874849142,0.0550163415696707,-0.0705872419916404,0.145076816961469,0.498442580455065
APOA2,Apolipoprotein A-II,Mental health,X28740.Difficulty with taking care of household responsibilities,35765,-0.0342838970213588,0.0635831290875134,-0.158906830032885,0.0903390359901674,0.589766990135566
APOA2,Apolipoprotein A-II,Mental health,X28741.Difficulty learning a new task,35726,-0.0107232697602437,0.0755064220085422,-0.158715856896986,0.137269317376499,0.887069817724597
APOA2,Apolipoprotein A-II,Mental health,X28742.Difficulty with joining in community activities,35360,0.0785103155491526,0.0695840952294924,-0.0578745111006526,0.214895142198958,0.259241912198861
APOA2,Apolipoprotein A-II,Mental health,X28743.Difficulty with being emotionally affected by health problems,35724,-0.12149746064706,0.0608518304010306,-0.24076704823308,-0.00222787306103964,0.0459054111528923
APOA2,Apolipoprotein A-II,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35772,0.0362721266336964,0.0818850138324446,-0.124222500477895,0.196766753745288,0.657805021480276
APOA2,Apolipoprotein A-II,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,34102,0.10844824210808,0.0535573366898378,0.00347586219599785,0.213420622020162,0.0429258590885648
APOA2,Apolipoprotein A-II,Lifestyle factors,X2897.Age stopped smoking,34610,0.00618752567225132,0.00706891413061776,-0.00766754602375949,0.0200425973682621,0.38143758350755
APOA2,Apolipoprotein A-II,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34919,-0.000650393274693939,0.0137502326318815,-0.0276008492331817,0.0263000626837938,0.962275201398023
APOA2,Apolipoprotein A-II,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34919,-0.00122946984867619,0.015453978515178,-0.0315192677384251,0.0290603280410727,0.936592234418069
APOA2,Apolipoprotein A-II,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34919,0.0368299280921754,0.0513178732936122,-0.0637531035633046,0.137412959747655,0.472979744284446
APOA2,Apolipoprotein A-II,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34919,-0.031457499729132,0.0527572321219597,-0.134861674688173,0.071946675229909,0.551016924657305
APOA2,Apolipoprotein A-II,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34919,-0.063642356088745,0.0611577551008741,-0.183511556086458,0.0562268439089683,0.298088927037945
APOA2,Apolipoprotein A-II,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34919,-0.0382977631944403,0.057782776252395,-0.151552004649135,0.074956478260254,0.507490154198389
APOA2,Apolipoprotein A-II,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34919,0.00703828949056622,0.0235770161794643,-0.0391726622211838,0.0532492412023162,0.765313584850885
APOA2,Apolipoprotein A-II,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34919,-0.00312525966637974,0.0453102022851999,-0.0919332561453715,0.085682736812612,0.945011904303173
APOA2,Apolipoprotein A-II,Mental health,X29002.Recent lack of interest or pleasure in doing things,34892,0.0116638227668474,0.0660437865350227,-0.117781998841797,0.141109644375492,0.859822451003175
APOA2,Apolipoprotein A-II,Mental health,X29003.Recent feelings of depression,34892,0.0305254668708865,0.0656445426455023,-0.098137836714298,0.159188770456071,0.641939322280004
APOA2,Apolipoprotein A-II,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34895,-0.0295919444615064,0.0518972077134283,-0.131310471579826,0.0721265826568132,0.568560365673333
APOA2,Apolipoprotein A-II,Mental health,X29005.Recent feelings of tiredness or low energy,34895,-0.05681726451435,0.05109527747013,-0.156964008355805,0.0433294793271047,0.266186384967714
APOA2,Apolipoprotein A-II,Mental health,X29006.Recent poor appetite or overeating,34902,0.0700614233202129,0.0801967167158688,-0.0871241414428899,0.227246988083316,0.382358748698164
APOA2,Apolipoprotein A-II,Mental health,X29007.Recent feelings of inadequacy,34883,0.0248094346829402,0.0720203084348189,-0.116350369849305,0.165969239215185,0.730498132253332
APOA2,Apolipoprotein A-II,Mental health,X29008.Recent trouble concentrating on things,34900,-0.00125985284496503,0.0692148843699908,-0.136921026210147,0.134401320520217,0.985478243147532
APOA2,Apolipoprotein A-II,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34895,0.088928632791993,0.118561125477532,-0.14345117314397,0.321308438727956,0.453243180922858
APOA2,Apolipoprotein A-II,Mental health,X29010.Recent thoughts of suicide or self-harm,34879,0.133812715026362,0.126874769213129,-0.114861832631372,0.382487262684095,0.291610732162072
APOA2,Apolipoprotein A-II,Mental health,X29038#0.Substances taken for depression_None of options listed,34966,-0.0585615929860282,0.0274715439282898,-0.112405819085476,-0.00471736688658014,0.0330681947731551
APOA2,Apolipoprotein A-II,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),34966,0.0527345048291244,0.049120645679067,-0.0435419607018469,0.149010970360096,0.283055655122448
APOA2,Apolipoprotein A-II,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),34966,-0.0230661657893412,0.0312665331242555,-0.0843485707128819,0.0382162391341995,0.460707550640324
APOA2,Apolipoprotein A-II,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),34966,-0.00387697928627356,0.0931992916227776,-0.186547590866918,0.178793632294371,0.966819829346949
APOA2,Apolipoprotein A-II,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),34966,-0.00919515102407073,0.0613415538830413,-0.129424596634832,0.11103429458669,0.88084759040929
APOA2,Apolipoprotein A-II,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),34966,-0.00745509672472933,0.0730942130719451,-0.150719754345742,0.135809560896283,0.918765458210349
APOA2,Apolipoprotein A-II,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),34966,-0.0772947997202244,0.0731193144003003,-0.220608655944813,0.0660190565043642,0.290503738782757
APOA2,Apolipoprotein A-II,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),34966,-0.0279711332523134,0.0839774727146516,-0.19256697977303,0.136624713268404,0.739085613831721
APOA2,Apolipoprotein A-II,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),34966,0.0503308599954592,0.0615983163418333,-0.0704018400345341,0.171063560025453,0.413912289319784
APOA2,Apolipoprotein A-II,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,34966,-0.0477284381481576,0.0260295857001815,-0.0987464261205133,0.00328954982419815,0.0667566868217027
APOA2,Apolipoprotein A-II,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,34966,-0.0515084001470678,0.0420628720352806,-0.133951629336218,0.0309348290420821,0.220787348460548
APOA2,Apolipoprotein A-II,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,34966,-0.136950354232606,0.0666216872832729,-0.267528861307821,-0.00637184715739125,0.0398577096277204
APOA2,Apolipoprotein A-II,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,34966,-0.0656619345887252,0.0789332161168597,-0.22037103817777,0.0890471690003198,0.405515245043293
APOA2,Apolipoprotein A-II,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,34966,-0.0342408707623661,0.0512031866604831,-0.134599116616913,0.0661173750921808,0.503694918262076
APOA2,Apolipoprotein A-II,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,34966,0.0405119678087267,0.0754470757909061,-0.107364300741449,0.188388236358903,0.591314870581378
APOA2,Apolipoprotein A-II,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,34966,-0.0652143692031815,0.0717619081340397,-0.205867709145899,0.0754389707395363,0.363511097579547
APOA2,Apolipoprotein A-II,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,34966,-0.0125549782221052,0.0415813084416748,-0.0940543427677878,0.0689443863235774,0.762709169771789
APOA2,Apolipoprotein A-II,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,34966,-0.0110368952821916,0.0408414078889772,-0.0910860547445868,0.0690122641802036,0.786986016175636
APOA2,Apolipoprotein A-II,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,34966,0.0286232164819829,0.0604498744595776,-0.0898585374587893,0.147104970422755,0.635870366780546
APOA2,Apolipoprotein A-II,Mental health,X29058.Recent feelings or nervousness or anxiety,34800,-0.0412233202475838,0.0643159734117501,-0.167282628134614,0.0848359876394465,0.521578895826353
APOA2,Apolipoprotein A-II,Mental health,X29059.Recent inability to stop or control worrying,34806,0.0145305403826224,0.0679557962072721,-0.118662820183631,0.147723900948876,0.830691791591097
APOA2,Apolipoprotein A-II,Mental health,X29060.Recent worrying too much about different things,34805,-0.0133737273972,0.0609176512516614,-0.132772323850456,0.106024869056056,0.826238358131312
APOA2,Apolipoprotein A-II,Mental health,X29061.Recent trouble relaxing,34801,-0.0926677284511586,0.0650105235253781,-0.2200883545609,0.0347528976585825,0.154084276486585
APOA2,Apolipoprotein A-II,Mental health,X29062.Recent restlessness,34808,-0.0838752396420585,0.0888491601050155,-0.258019593447889,0.090269114163772,0.345197008223271
APOA2,Apolipoprotein A-II,Mental health,X29063.Recent easy annoyance or irritability,34798,-0.0997709377737423,0.0621297307556953,-0.221545210054905,0.0220033345074205,0.108358151033071
APOA2,Apolipoprotein A-II,Mental health,X29064.Recent feelings of foreboding,34802,-0.0360779615955275,0.0773495530501729,-0.187683085573866,0.115527162382811,0.640925891253411
APOA2,Apolipoprotein A-II,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,34966,-0.0496311302796447,0.0324971124876827,-0.113325470755503,0.0140632101962134,0.126749186301966
APOA2,Apolipoprotein A-II,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,34966,-0.0895351287578667,0.0495197367472741,-0.186593812782524,0.00752355526679045,0.0706428477668626
APOA2,Apolipoprotein A-II,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',34966,-0.0399383919139719,0.0684351569063722,-0.174071299450461,0.0941945156225175,0.559513731062778
APOA2,Apolipoprotein A-II,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,34966,-0.00613906538668235,0.0666644900719384,-0.136801465927682,0.124523335154317,0.926630235649557
APOA2,Apolipoprotein A-II,Mental health,X29065#2.Symptoms of panic attack_Sweating,34966,-0.0634349402529751,0.0428683803799205,-0.147456965797619,0.0205870852916691,0.138986629679302
APOA2,Apolipoprotein A-II,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,34966,-0.0220238066553867,0.0538743179385457,-0.127617469814936,0.0835698565041629,0.682700388853246
APOA2,Apolipoprotein A-II,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,34966,-0.0784585323619079,0.0504902321554279,-0.177419387386547,0.0205023226627308,0.120249662599781
APOA2,Apolipoprotein A-II,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,34966,-0.0240107557073103,0.0522722675955997,-0.126464400194686,0.0784428887800652,0.64600554270315
APOA2,Apolipoprotein A-II,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,34966,-0.0619787302688451,0.0635750612327807,-0.186585850285095,0.0626283897474051,0.329651566495929
APOA2,Apolipoprotein A-II,Mental health,X29076.Felt loved as a child,34777,0.0602652592944449,0.0519738685690965,-0.0416035231009842,0.162134041689874,0.246285060171935
APOA2,Apolipoprotein A-II,Mental health,X29077.Physically abused by family as a child,34786,-0.0465536520444855,0.0665937846046388,-0.177077469869578,0.0839701657806066,0.484535190435802
APOA2,Apolipoprotein A-II,Mental health,X29078.Felt hated by family member as a child,34779,-0.0137527749845649,0.0755994915719271,-0.161927778465542,0.134422228496412,0.855654432457235
APOA2,Apolipoprotein A-II,Mental health,X29079.Sexually molested as a child,34762,0.0481792826801559,0.113023473995073,-0.173346726350188,0.2697052917105,0.669921072036125
APOA2,Apolipoprotein A-II,Mental health,X29080.Someone to take to doctor when needed as a child,34773,0.0802559272856098,0.0784067771293851,-0.0734213558879849,0.233933210459205,0.306071906481567
APOA2,Apolipoprotein A-II,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34781,0.19254387465871,0.11642130108809,-0.0356418754739471,0.420729624791366,0.0982078978004327
APOA2,Apolipoprotein A-II,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34766,-0.0261313527097765,0.0978262350600149,-0.217870773427406,0.165608068007853,0.789385634633483
APOA2,Apolipoprotein A-II,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34792,-0.159262157527168,0.109788643236305,-0.374447898270326,0.0559235832159911,0.146934953943203
APOA2,Apolipoprotein A-II,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34786,-0.707677127983795,0.317748354488284,-1.33046390278083,-0.0848903531867586,0.0259722882685374
APOA2,Apolipoprotein A-II,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34779,-0.199191695073258,0.206542532072512,-0.604015057935381,0.205631667788865,0.334878129674001
APOA2,Apolipoprotein A-II,Mental health,X29086.Experienced a violent or sexual assault,34796,0.141792288494599,0.118959591901211,-0.0913685116317753,0.374953088620973,0.233331773189726
APOA2,Apolipoprotein A-II,Mental health,X29087.Experienced a life-threatening injury or illness,34789,-0.00894127347140085,0.0584676942798346,-0.123537954259877,0.105655407317075,0.878461040147291
APOA2,Apolipoprotein A-II,Mental health,X29088.Experienced a marital separation or divorce,34789,0.0056595147536327,0.058748230810857,-0.109487017635647,0.120806047142912,0.923257580743658
APOA2,Apolipoprotein A-II,Mental health,X29089.Experienced the death of a spouse or partner,34800,-0.0139970464581754,0.0878869498557377,-0.186255468175421,0.158261375259071,0.873467690942483
APOA2,Apolipoprotein A-II,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34790,-0.031601843191993,0.0725289454178022,-0.173758576210885,0.110554889826899,0.663059779921332
APOA2,Apolipoprotein A-II,Lifestyle factors,X29091.Frequency of drinking alcohol,34785,0.135847105491647,0.0479444914745321,0.041875902201564,0.22981830878173,0.00462013316683314
APOA2,Apolipoprotein A-II,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,34273,0.155870701440814,0.0509120370516166,0.0560831088196458,0.255658294061983,0.0022121162706443
APOA2,Apolipoprotein A-II,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,34292,0.19608290490185,0.0512378691161509,0.0956566814341942,0.296509128369506,0.000131151488039761
APOA2,Apolipoprotein A-II,Mental health,X29104.Ever used cannabis,34782,-0.00280209656521543,0.0642177888941567,-0.128668962797763,0.123064769667332,0.965197341306664
APOA2,Apolipoprotein A-II,Mental health,X29108.Ever thought that life not worth living,34761,0.0219061927775909,0.0641819162377725,-0.103890363048443,0.147702748603625,0.732878777998927
APOA2,Apolipoprotein A-II,Mental health,X29109.Ever contemplated self-harm,34764,0.100585006586004,0.0909279343125714,-0.077633744666636,0.278803757838644,0.268680638865818
APOA2,Apolipoprotein A-II,Mental health,X29111.Ever self-harmed,34776,0.126037188192333,0.159006857008999,-0.185616251545304,0.437690627929971,0.428010743680474
APOA2,Apolipoprotein A-II,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34778,0.0427618802442632,0.0956983988086632,-0.144806981420717,0.230330741909243,0.655006195353136
APOA2,Apolipoprotein A-II,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,35448,-0.0637621104033423,0.0693748799698052,-0.19973687514416,0.0722126543374759,0.358078217460248
APOA2,Apolipoprotein A-II,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,35448,-0.0373526380839934,0.0538632938856247,-0.142924694099818,0.068219417931831,0.488037471022014
APOA2,Apolipoprotein A-II,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,35448,0.0237246236519745,0.0644681682778919,-0.102632986172694,0.150082233476643,0.71288070201708
APOA2,Apolipoprotein A-II,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,35448,0.0405733673455574,0.10690596106569,-0.168962316343196,0.250109051034311,0.704310627544774
APOA2,Apolipoprotein A-II,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34767,0.107583422742249,0.05526231083815,-0.000730706500525202,0.215897551985023,0.051606766369037
APOA2,Apolipoprotein A-II,Health and medical history,X29153.Pain or discomfort today,34778,0.00932614799105664,0.0505497639656664,-0.0897513893816494,0.108403685363763,0.85363168429875
APOA2,Apolipoprotein A-II,Mental health,X29154.Anxiety or depression today,34778,-0.067197118464502,0.0675083106321145,-0.199513407303446,0.0651191703744423,0.319585470957157
APOA2,Apolipoprotein A-II,Mental health,X29166.Frequency of confiding in someone close,34622,0.0210245580417866,0.0505366694501081,-0.0780273140804253,0.120076430163998,0.677405963283581
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34764,-0.00629054723438037,0.0129868423938236,-0.0317447583262747,0.019163663857514,0.628134484118726
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34764,0.0113939960140636,0.0134651455508157,-0.0149976892655351,0.0377856812936623,0.397482734968893
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34764,0.011086343223419,0.0143053857168297,-0.0169522127815672,0.0391248992284052,0.438383047291672
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34764,-0.0174417002683979,0.0196176952524356,-0.0558923829631717,0.0210089824263758,0.373994787430207
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34764,-0.0961726117059608,0.0390256499357744,-0.172662885580079,-0.019682337831843,0.0137535305127513
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34764,0.00345481675172302,0.0144597283000434,-0.0248862507163621,0.0317958842198081,0.811170279439668
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34759,-0.00318211981059238,0.0151460140742574,-0.0328683073961368,0.026504067774952,0.833599550616153
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34759,0.00559565376860906,0.0237996901871234,-0.0410517389981529,0.052243046535371,0.814127631841769
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34759,0.0151360441615989,0.0271973934582338,-0.0381708470165393,0.0684429353397371,0.577871857195995
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34759,-0.0273825411379499,0.0332578206623515,-0.0925678696361588,0.0378027873602589,0.410345746545457
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34759,-0.0578539051291944,0.0562264181076624,-0.168057684620213,0.0523498743618239,0.303545814889851
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34759,-0.00177109796433331,0.0217319637498598,-0.0443657469140586,0.040823550985392,0.935049061777194
APOA2,Apolipoprotein A-II,Mental health,X29171.Frequency of feeling 'in tune' with people,34609,0.0350111589758872,0.0614354605988176,-0.0854023437977954,0.15542466174957,0.568776880151104
APOA2,Apolipoprotein A-II,Mental health,X29172.Freuency of feeling that lacks companionship,34722,0.026104717026904,0.0580136995720433,-0.087602134134301,0.139811568188109,0.652744369928062
APOA2,Apolipoprotein A-II,Mental health,X29173.Frequency of feeling left out,34696,-0.0959106957737224,0.0600214327172706,-0.213552703899573,0.0217313123521279,0.110107991025837
APOA2,Apolipoprotein A-II,Mental health,X29174.Frequency of feeling isolated from others,34725,-0.0803616587629515,0.0614439534463253,-0.200791807517749,0.0400684899918461,0.190961223928763
APOA2,Apolipoprotein A-II,Mental health,X29175.Tendency to bounce back quickly after hard times,34771,0.164060843422755,0.0497247785739515,0.0666002774178098,0.2615214094277,0.000974489747228307
APOA2,Apolipoprotein A-II,Mental health,X29176.Ability to make it through stressful events,34771,-0.0426910868360033,0.0480377509957487,-0.136845078787671,0.0514629051156641,0.374199685976938
APOA2,Apolipoprotein A-II,Mental health,X29177.Quick recovery from stressful events,34771,0.123388569869563,0.0494869250624854,0.0263941967470919,0.220382942992035,0.0126801609684957
APOA2,Apolipoprotein A-II,Mental health,X29178.Hard to snap back when something bad happens,34771,-0.0940938076218044,0.0484664443410197,-0.189088038530203,0.000900423286594274,0.0522526307537053
APOA2,Apolipoprotein A-II,Mental health,X29179.Comes through difficult times with little trouble,34771,0.0935205028440397,0.0492363018490411,-0.00298264878008081,0.19002365446816,0.0575556517469997
APOA2,Apolipoprotein A-II,Mental health,X29180.Tendency to take a long time to get over setbacks,34771,-0.0519618358139186,0.0486106505149975,-0.147238710823314,0.0433150391954765,0.285138842836197
APOA2,Apolipoprotein A-II,Mental health,X29181.General happiness,34737,-0.12407945345138,0.0504187356077533,-0.222900175242576,-0.0252587316601835,0.0138831923819331
APOA2,Apolipoprotein A-II,Mental health,X29182.Belief that own life is meaningful,34658,0.0741651647338762,0.0510340606711897,-0.0258615941816556,0.174191923649408,0.146206633413516
APOA2,Apolipoprotein A-II,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,34032,-0.0535034116053601,0.0479226504511093,-0.147431806489534,0.040424983278814,0.26427744845368
APOA2,Apolipoprotein A-II,Health and medical history,X2946.Father's age,32895,0.00378256931486292,0.0114569940265871,-0.0186731389772477,0.0262382776069736,0.741299908395626
APOA2,Apolipoprotein A-II,Health and medical history,X2966.Age high blood pressure diagnosed,34554,-0.041801964160963,0.00937153995290291,-0.0601701824686527,-0.0234337458532733,8.32636752411653e-06
APOA2,Apolipoprotein A-II,Blood and urine assays,X30000.White blood cell (leukocyte) count,48540,-0.0267786649398228,0.00384266349000986,-0.0343102853802422,-0.0192470444994035,3.29684114610662e-12
APOA2,Apolipoprotein A-II,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,48541,-0.0526891589459531,0.00414414589219462,-0.0608116848946545,-0.0445666329972516,6.8655492947792e-37
APOA2,Apolipoprotein A-II,Blood and urine assays,X30020.Haemoglobin concentration,48541,-0.0640882985152012,0.00437820591338687,-0.0726695821054394,-0.0555070149249629,2.8604445883478e-48
APOA2,Apolipoprotein A-II,Blood and urine assays,X30030.Haematocrit percentage,48541,-0.0472370252411653,0.00430555098600184,-0.0556759051737289,-0.0387981453086017,6.31899966652516e-28
APOA2,Apolipoprotein A-II,Blood and urine assays,X30040.Mean corpuscular volume,48541,0.0208171685810261,0.00380544421354069,0.0133584979224864,0.0282758392395659,4.54511438811769e-08
APOA2,Apolipoprotein A-II,Blood and urine assays,X30050.Mean corpuscular haemoglobin,48541,-0.000164751607204112,0.00381257362611903,-0.00763739591439741,0.00730789269998919,0.965532412633302
APOA2,Apolipoprotein A-II,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,48541,-0.0348974795450804,0.00371234655627246,-0.0421736787953745,-0.0276212802947864,6.00709480922022e-21
APOA2,Apolipoprotein A-II,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,48541,0.0457748005070695,0.00386899243732328,0.0381915753299159,0.0533580256842232,3.45071407114814e-32
APOA2,Apolipoprotein A-II,Blood and urine assays,X30080.Platelet count,48541,0.00801574116518194,0.00380595310722217,0.000556073075026478,0.0154754092553374,0.0352075994514412
APOA2,Apolipoprotein A-II,Blood and urine assays,X30090.Platelet crit,48541,0.0070090963142136,0.00387716722978015,-0.000590151456155499,0.0146083440845827,0.0706545664313805
APOA2,Apolipoprotein A-II,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,48541,-0.00401867393574517,0.00359998299397219,-0.0110746406039307,0.00303729273244032,0.26430565685294
APOA2,Apolipoprotein A-II,Blood and urine assays,X30110.Platelet distribution width,48541,-0.0161420693886708,0.00370268134614564,-0.0233993248271162,-0.00888481395022533,1.30975317065359e-05
APOA2,Apolipoprotein A-II,Blood and urine assays,X30120.Lymphocyte count,48507,-0.0618444601144869,0.00371256962437685,-0.0691210965782655,-0.0545678236507083,6.93404433140149e-62
APOA2,Apolipoprotein A-II,Blood and urine assays,X30130.Monocyte count,48507,-0.0291970752810192,0.00375417705280256,-0.0365552623045122,-0.0218388882575262,7.77285856836248e-15
APOA2,Apolipoprotein A-II,Blood and urine assays,X30140.Neutrophill count,48507,-0.00287175487163394,0.00380416688624418,-0.0103279219686725,0.00458441222540466,0.450319605780021
APOA2,Apolipoprotein A-II,Blood and urine assays,X30150.Eosinophill count,48507,-0.0125419701674425,0.00361240402039403,-0.0196222820474148,-0.00546165828747017,0.000517850694023932
APOA2,Apolipoprotein A-II,Blood and urine assays,X30160.Basophill count,48507,-0.0888730962136478,0.0286071148933791,-0.144943041404671,-0.0328031510226247,0.00189468388690007
APOA2,Apolipoprotein A-II,Blood and urine assays,X30170.Nucleated red blood cell count,48507,0.0880331752460104,0.145193438897732,-0.196545964993544,0.372612315485565,0.54431152917002
APOA2,Apolipoprotein A-II,Blood and urine assays,X30180.Lymphocyte percentage,48508,-0.0432747125053633,0.00368991558184455,-0.0505069470457786,-0.036042477964948,1.16662724880514e-31
APOA2,Apolipoprotein A-II,Blood and urine assays,X30190.Monocyte percentage,48508,-0.0108148838222686,0.00371675429431581,-0.0180997222391276,-0.0035300454054096,0.00362100312888849
APOA2,Apolipoprotein A-II,Blood and urine assays,X30200.Neutrophill percentage,48508,0.03899303534884,0.00364120773772049,0.0318562681829079,0.0461298025147722,1.09394477412058e-26
APOA2,Apolipoprotein A-II,Blood and urine assays,X30210.Eosinophill percentage,48508,-0.00465087160023263,0.00358644188315367,-0.0116802976912138,0.00237855449074856,0.194717557962889
APOA2,Apolipoprotein A-II,Blood and urine assays,X30220.Basophill percentage,48508,-0.00288146243554315,0.00375582998028081,-0.0102428891968935,0.00447996432580723,0.442973345406606
APOA2,Apolipoprotein A-II,Blood and urine assays,X30230.Nucleated red blood cell percentage,48507,0.0914722899132939,0.145805843998121,-0.194307164323024,0.377251744149612,0.530432564475187
APOA2,Apolipoprotein A-II,Blood and urine assays,X30240.Reticulocyte percentage,48188,-0.0174197551899744,0.00395616729514466,-0.025173843088458,-0.0096656672914909,1.07235520706022e-05
APOA2,Apolipoprotein A-II,Blood and urine assays,X30250.Reticulocyte count,48188,-0.0289601658948795,0.00399795543746929,-0.0367961585523193,-0.0211241732374397,4.52646565360294e-13
APOA2,Apolipoprotein A-II,Blood and urine assays,X30260.Mean reticulocyte volume,48188,0.0526422400149998,0.00373594541254622,0.0453197870064092,0.0599646930235904,7.17313725131215e-45
APOA2,Apolipoprotein A-II,Blood and urine assays,X30270.Mean sphered cell volume,48188,0.0321472516263094,0.0037655660623367,0.0247667421441295,0.0395277611084893,1.4745374385333e-17
APOA2,Apolipoprotein A-II,Blood and urine assays,X30280.Immature reticulocyte fraction,48188,0.0169698638346212,0.00389621367659653,0.00933328502849199,0.0246064426407504,1.33452510122539e-05
APOA2,Apolipoprotein A-II,Blood and urine assays,X30290.High light scatter reticulocyte percentage,48188,-0.00591146924746376,0.00400996738401356,-0.0137710053201303,0.00194806682520281,0.140445476338545
APOA2,Apolipoprotein A-II,Blood and urine assays,X30300.High light scatter reticulocyte count,48188,-0.0151109833242912,0.00403002009528594,-0.0230098227110517,-0.00721214393753077,0.000177622828960027
APOA2,Apolipoprotein A-II,Blood and urine assays,X30500.Microalbumin in urine,35919,0.0443223392524335,0.00609320781213417,0.0323796519406505,0.0562650265642165,3.85054195383084e-13
APOA2,Apolipoprotein A-II,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,48582,-0.0261092133846132,0.00400123594246805,-0.0339516358318505,-0.0182667909373758,6.94994715718073e-11
APOA2,Apolipoprotein A-II,Blood and urine assays,X30520.Potassium in urine,48545,-0.0194719185376096,0.00372902718483064,-0.0267808118198777,-0.0121630252553416,1.79052013421918e-07
APOA2,Apolipoprotein A-II,Blood and urine assays,X30530.Sodium in urine,48551,-0.0275859588284218,0.0038651721107567,-0.035161696165505,-0.0200102214913387,9.8619542639489e-13
APOA2,Apolipoprotein A-II,Blood and urine assays,X30600.Albumin,46670,0.000350413575705138,0.00395853682184035,-0.00740831859510195,0.00810914574651222,0.929463587741728
APOA2,Apolipoprotein A-II,Blood and urine assays,X30610.Alkaline phosphatase,48168,-0.0385915926235787,0.00390588869275079,-0.0462471344613702,-0.0309360507857872,5.73264970718622e-23
APOA2,Apolipoprotein A-II,Blood and urine assays,X30620.Alanine aminotransferase,48153,-0.0442764018544354,0.00421054378588388,-0.0525290676747678,-0.036023736034103,8.57911799657268e-26
APOA2,Apolipoprotein A-II,Blood and urine assays,X30630.Apolipoprotein A,46613,0.190056384629296,0.00405533700864423,0.182107924092353,0.198004845166238,0
APOA2,Apolipoprotein A-II,Blood and urine assays,X30640.Apolipoprotein B,48024,-0.0471818319971323,0.00363358020032276,-0.0543036491897649,-0.0400600148044997,2.15230186776678e-38
APOA2,Apolipoprotein A-II,Blood and urine assays,X30650.Aspartate aminotransferase,48095,0.00511935642501311,0.00388729626743639,-0.0024997442591622,0.0127384571091884,0.187872450965737
APOA2,Apolipoprotein A-II,Blood and urine assays,X30660.Direct bilirubin,46804,0.0551085205726943,0.00391329340840658,0.0474384654922174,0.0627785756531712,8.37632616991321e-45
APOA2,Apolipoprotein A-II,Blood and urine assays,X30670.Urea,48157,0.0165547595522405,0.00387068015772424,0.00896822644310098,0.02414129266138,1.9035836478908e-05
APOA2,Apolipoprotein A-II,Blood and urine assays,X30680.Calcium,46662,0.0173809368443467,0.00392763211574782,0.009682777897481,0.0250790957912125,9.68736334012279e-06
APOA2,Apolipoprotein A-II,Blood and urine assays,X30690.Cholesterol,48171,-0.015410702512269,0.00369102197306261,-0.0226451055794717,-0.00817629944506626,2.99030771872712e-05
APOA2,Apolipoprotein A-II,Blood and urine assays,X30700.Creatinine,48163,0.0904696340538503,0.00482550613243629,0.0810116420342752,0.0999276260734254,9.61383659680344e-78
APOA2,Apolipoprotein A-II,Blood and urine assays,X30710.C-reactive protein,48096,-0.0326790716575778,0.00406644875621112,-0.0406493112197516,-0.024708832095404,9.78533684086221e-16
APOA2,Apolipoprotein A-II,Blood and urine assays,X30720.Cystatin C,48177,0.115670345768173,0.00439553658737918,0.10705509405691,0.124285597479436,5.15854341936324e-150
APOA2,Apolipoprotein A-II,Blood and urine assays,X30730.Gamma glutamyltransferase,48159,0.0126950391707337,0.00444755126668098,0.00397783868803901,0.0214122396534285,0.0043165081181296
APOA2,Apolipoprotein A-II,Blood and urine assays,X30740.Glucose,46640,-0.0027835131063533,0.00375798678554333,-0.0101491672060182,0.00458214099331162,0.458889470820056
APOA2,Apolipoprotein A-II,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),48074,-0.00787281581869675,0.00376127236573729,-0.0152449096555418,-0.000500721981851656,0.0363508407690967
APOA2,Apolipoprotein A-II,Blood and urine assays,X30760.HDL cholesterol,46650,0.185862565866433,0.00421558605052984,0.177600017207394,0.194125114525471,0
APOA2,Apolipoprotein A-II,Blood and urine assays,X30770.IGF-1,48080,-0.0207053311894419,0.0039218177288068,-0.0283920939379032,-0.0130185684409805,1.30908737972747e-07
APOA2,Apolipoprotein A-II,Blood and urine assays,X30780.LDL direct,48126,-0.0401217395902268,0.00367505751610127,-0.0473248523217853,-0.0329186268586684,1.14544155083385e-27
APOA2,Apolipoprotein A-II,Blood and urine assays,X30790.Lipoprotein A,44232,-0.0121470659208069,0.00401852666064354,-0.0200233781756682,-0.00427075366594553,0.00250881573822828
APOA2,Apolipoprotein A-II,Blood and urine assays,X30810.Phosphate,46622,0.0129627042688513,0.00383301026155815,0.00545000415619737,0.0204754043815053,0.000721498253939044
APOA2,Apolipoprotein A-II,Blood and urine assays,X30830.SHBG,46537,0.108484046620042,0.00502268278601562,0.0986395883594514,0.118328504880633,3.68031848549203e-102
APOA2,Apolipoprotein A-II,Blood and urine assays,X30840.Total bilirubin,48086,0.0418851841122057,0.00400590971342922,0.0340336010738844,0.049736767150527,1.60946243852016e-25
APOA2,Apolipoprotein A-II,Blood and urine assays,X30850.Testosterone,47977,0.0845879274048167,0.00625852551582295,0.0723212173938037,0.0968546374158297,1.94899461239588e-41
APOA2,Apolipoprotein A-II,Blood and urine assays,X30860.Total protein,46641,0.00675158431602247,0.00390096492674757,-0.000894306940402757,0.0143974755724477,0.0835139526667314
APOA2,Apolipoprotein A-II,Blood and urine assays,X30870.Triglycerides,48149,-0.102859546011475,0.0037711676486355,-0.110251034602801,-0.0954680574201495,8.45844288096456e-161
APOA2,Apolipoprotein A-II,Blood and urine assays,X30880.Urate,48144,0.0163156191354118,0.00465468632205911,0.00719243394417591,0.0254388043266476,0.000457281452699283
APOA2,Apolipoprotein A-II,Blood and urine assays,X30890.Vitamin D,47577,0.0236981541575735,0.00414628723732815,0.0155714311724103,0.0318248771427367,1.11015193848073e-08
APOA2,Apolipoprotein A-II,Physical measures,X3137.Number of measurements made,47020,-0.0318270413024375,0.0345040588816853,-0.0994549967105406,0.0358009141056656,0.356324535565105
APOA2,Apolipoprotein A-II,Physical measures,X3143.Ankle spacing width,40136,0.00595304990459798,0.00668297344908163,-0.00714557805560202,0.019051677864798,0.373066521350869
APOA2,Apolipoprotein A-II,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",40136,-0.00996997173767405,0.00485820893414769,-0.0194920612486035,-0.000447882226744571,0.04017363925184
APOA2,Apolipoprotein A-II,Physical measures,X3146.Speed of sound through heel,40136,-0.00658325807063175,0.00471638026405774,-0.0158273633881849,0.00266084724692143,0.162793003307291
APOA2,Apolipoprotein A-II,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",40136,-0.00788159423176461,0.00475517705843176,-0.0172017412662909,0.00143855280276164,0.0974503670678889
APOA2,Apolipoprotein A-II,Physical measures,X3148.Heel bone mineral density (BMD),40117,-0.00657144079229874,0.00478906646075817,-0.0159580110553848,0.00281512947078728,0.170035461490206
APOA2,Apolipoprotein A-II,Health and medical history,X3526.Mother's age at death,40854,-0.00316651711110787,0.00480394737859351,-0.0125822539731511,0.00624921975093542,0.509812478700806
APOA2,Apolipoprotein A-II,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32390,-0.0153246501636756,0.00879138912832352,-0.0325557728551897,0.0019064725278385,0.0813896983881649
APOA2,Apolipoprotein A-II,Physical measures,X4100.Ankle spacing width (left),35262,0.0126141819514034,0.00895519907626212,-0.00493800823807036,0.0301663721408771,0.159003828974189
APOA2,Apolipoprotein A-II,Physical measures,X4101.Heel broadband ultrasound attenuation (left),35261,-0.006427078878996,0.00649000870302161,-0.0191474959369184,0.00629333817892636,0.322061726527006
APOA2,Apolipoprotein A-II,Physical measures,X4103.Speed of sound through heel (left),35262,-0.00714551435241919,0.0062212306460405,-0.0193391264186586,0.00504809771382019,0.250774871308527
APOA2,Apolipoprotein A-II,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",35262,-0.00710673380221493,0.00630845086069614,-0.0194712974891794,0.0052578298847495,0.259976820403483
APOA2,Apolipoprotein A-II,Physical measures,X4105.Heel bone mineral density (BMD) (left),35254,-0.00743194973392274,0.00634023171163088,-0.0198588038887193,0.00499490442087378,0.241163158292375
APOA2,Apolipoprotein A-II,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",35262,-0.00709625685111654,0.00630892212536455,-0.019461744216831,0.00526923051459798,0.260715577820236
APOA2,Apolipoprotein A-II,Physical measures,X4119.Ankle spacing width (right),35250,0.0101666068892596,0.00882456229493329,-0.00712953520880966,0.0274627489873288,0.249329375452645
APOA2,Apolipoprotein A-II,Physical measures,X4120.Heel broadband ultrasound attenuation (right),35249,-0.0123215303320815,0.00653471806796887,-0.0251295777453005,0.000486517081137462,0.0593993299991173
APOA2,Apolipoprotein A-II,Physical measures,X4122.Speed of sound through heel (right),35250,-0.0093482615671132,0.00619478204089535,-0.0214900343672681,0.00279351123304169,0.131332451907416
APOA2,Apolipoprotein A-II,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",35250,-0.0106714780133553,0.00630910102042059,-0.0230373160133796,0.00169435998666908,0.0907992846316937
APOA2,Apolipoprotein A-II,Physical measures,X4124.Heel bone mineral density (BMD) (right),35241,-0.0111258653761229,0.00632994794321484,-0.023532563344824,0.00128083259257818,0.0788522767807424
APOA2,Apolipoprotein A-II,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",35250,-0.0106732960939492,0.00630913662605539,-0.0230392038810178,0.00169261169311934,0.0907461201090036
APOA2,Apolipoprotein A-II,Physical measures,X4194.Pulse rate,35598,-0.0266413760140266,0.00587830498111271,-0.0381628537770075,-0.0151198982510457,5.93559490917473e-06
APOA2,Apolipoprotein A-II,Physical measures,X4195.Pulse wave reflection index,35598,-0.00351679202818613,0.00616811245240917,-0.0156062924349081,0.00857270837853585,0.568589572599994
APOA2,Apolipoprotein A-II,Physical measures,X4196.Pulse wave peak to peak time,35590,0.0152079654471092,0.00684039000285443,0.00180080104151457,0.0286151298527039,0.0262301247257217
APOA2,Apolipoprotein A-II,Physical measures,X4198.Position of the pulse wave peak,35598,-0.0163549529899318,0.00735812449214756,-0.030776876994541,-0.00193302898532262,0.026267413292446
APOA2,Apolipoprotein A-II,Physical measures,X4199.Position of pulse wave notch,35598,-0.0178945367648102,0.00594764410412453,-0.0295519192088942,-0.00623715432072609,0.00263322296075007
APOA2,Apolipoprotein A-II,Physical measures,X4200.Position of the shoulder on the pulse waveform,35598,-0.0215059602161817,0.00749591294510587,-0.0361979495885892,-0.00681397084377416,0.00412972099302734
APOA2,Apolipoprotein A-II,Physical measures,X4269.Number of triplets attempted (left),35395,0.0228934481750914,0.140807793699961,-0.253089827476831,0.298876723827014,0.870848851340529
APOA2,Apolipoprotein A-II,Physical measures,X4270.Volume level set by participant (left),35317,0.0240946517469278,0.0441800905036846,-0.0624983256402941,0.11068762913415,0.585514761173519
APOA2,Apolipoprotein A-II,Physical measures,X4276.Number of triplets attempted (right),35400,0.0398241293235351,0.140370359467469,-0.235301775232705,0.314950033879775,0.776643170061605
APOA2,Apolipoprotein A-II,Physical measures,X4277.Volume level set by participant (right),35325,0.0324397459383135,0.0438859379272478,-0.0535766923990922,0.118456184275719,0.459821600080149
APOA2,Apolipoprotein A-II,Cognitive function,X4288.Time to answer,35567,0.00351370478561205,0.00706374540023161,-0.0103312361988419,0.017358645770066,0.618902958571963
APOA2,Apolipoprotein A-II,Cognitive function,X4290.Duration screen displayed,35567,7.6213051853752e-05,0.00650232820239028,-0.0126683502248312,0.0128207763285387,0.990648635217036
APOA2,Apolipoprotein A-II,Physical measures,X46.Hand grip strength (left),49062,-0.0236385609743429,0.00489219118835219,-0.0332272557035132,-0.0140498662451727,1.36218025206037e-06
APOA2,Apolipoprotein A-II,Physical measures,X47.Hand grip strength (right),49058,-0.0198964262728284,0.00482267802727299,-0.0293488752062835,-0.0104439773393734,3.71236132080405e-05
APOA2,Apolipoprotein A-II,Physical measures,X48.Waist circumference,49115,-0.0507283396869365,0.00915179007512304,-0.0686658482341777,-0.0327908311396954,3.00998047614504e-08
APOA2,Apolipoprotein A-II,Health and medical history,X4803.Tinnitus,35436,-0.0802785480938344,0.0496677877301778,-0.177627412044983,0.0170703158573141,0.106073442947532
APOA2,Apolipoprotein A-II,Working and living environment,X4825.Noisy workplace,35504,-0.0104035668449475,0.0475537034370283,-0.103608825581523,0.0828016918916279,0.826831702717438
APOA2,Apolipoprotein A-II,Working and living environment,X4836.Loud music exposure frequency,35461,0.0137634076666503,0.0637654826124442,-0.11121693825374,0.138743753587041,0.829115635252327
APOA2,Apolipoprotein A-II,Physical measures,X49.Hip circumference,49108,-0.0162965238464873,0.00672640963292418,-0.0294802867270187,-0.00311276096595588,0.0154114016237712
APOA2,Apolipoprotein A-II,Physical measures,X50.Standing height,49072,-0.0135395759898365,0.0050939589222807,-0.0235237354775066,-0.00355541650216629,0.00786746030762326
APOA2,Apolipoprotein A-II,Health and medical history,X5057.Number of older siblings,34698,-0.00246691527531612,0.0468127709301779,-0.0942199462984648,0.0892861157478325,0.957974669657775
APOA2,Apolipoprotein A-II,Physical measures,X51.Seated height,48988,-0.0243409687392209,0.00443522900603254,-0.0330340175910447,-0.0156479198873971,4.11125597459403e-08
APOA2,Apolipoprotein A-II,Eye measures,X5181.Ever had eye surgery,33319,0.285537866874546,0.104547716232444,0.0806243430589563,0.490451390690135,0.00633440873328109
APOA2,Apolipoprotein A-II,Eye measures,X5186.Duration visual-acuity screen displayed (right),33309,0.00788407889819905,0.0076693449779413,-0.00714783725856591,0.022915995054964,0.304003102078788
APOA2,Apolipoprotein A-II,Eye measures,X5188.Duration visual-acuity screen displayed (left),33306,0.0116853010086188,0.00790399142040891,-0.00380652217538267,0.0271771241926203,0.139366313751126
APOA2,Apolipoprotein A-II,Eye measures,X5190.Duration at which refractometer first shown (right),33261,0.0120670964299449,0.00792011316202625,-0.00345632536762655,0.0275905182275164,0.127676125221192
APOA2,Apolipoprotein A-II,Eye measures,X5193.Duration at which refractometer first shown (left),33258,0.0172085516424579,0.00799535134542684,0.00153766300542126,0.0328794402794945,0.031423409004995
APOA2,Apolipoprotein A-II,Eye measures,"X5199.logMAR, initial (right)",33288,0.104933468393412,0.0543970053914348,-0.0016846621738002,0.211551598960624,0.053787414496304
APOA2,Apolipoprotein A-II,Eye measures,X5200.Final number of letters displayed (right),33288,-0.462229126265162,0.314997698234038,-1.07962461480388,0.155166362273552,0.142333087219041
APOA2,Apolipoprotein A-II,Eye measures,"X5201.logMAR, final (right)",33232,0.0251511345641343,0.00757446248933525,0.0103051880850373,0.0399970810432314,0.00090546120005913
APOA2,Apolipoprotein A-II,Eye measures,X5202.Number of rounds to result (right),33288,-0.0404993774298557,0.0516239823389332,-0.141682382814165,0.0606836279544533,0.43278238638957
APOA2,Apolipoprotein A-II,Eye measures,"X5206.logMAR, initial (left)",33284,0.155828328701926,0.054209193175181,0.049578310078571,0.26207834732528,0.00406396426134379
APOA2,Apolipoprotein A-II,Eye measures,X5207.Final number of letters displayed (left),33284,-0.919817716648972,0.294841100057402,-1.49770627276148,-0.341929160536465,0.00182131812420194
APOA2,Apolipoprotein A-II,Eye measures,"X5208.logMAR, final (left)",33246,0.0288908981486216,0.00764877984387352,0.0138992896546295,0.0438825066426137,0.00016059121865849
APOA2,Apolipoprotein A-II,Eye measures,X5209.Number of rounds to result (left),33280,-0.0165012719166861,0.0516346249335807,-0.117705136786504,0.0847025929531321,0.749302819891176
APOA2,Apolipoprotein A-II,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",33114,-0.0103790083839539,0.00752875588407218,-0.0251353699167354,0.00437735314882755,0.168091941342152
APOA2,Apolipoprotein A-II,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",33114,-0.0108617512821433,0.00741383880129099,-0.0253928753326736,0.00366937276838706,0.142972992562566
APOA2,Apolipoprotein A-II,Eye measures,X5256.Corneal hysteresis (right),33114,0.00270094080493354,0.0076562935678952,-0.012305394588141,0.0177072761980081,0.724274397266196
APOA2,Apolipoprotein A-II,Eye measures,X5257.Corneal resistance factor (right),33114,-0.00393482974775318,0.00755594337156801,-0.0187444787560265,0.0108748192605201,0.60255982000664
APOA2,Apolipoprotein A-II,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",33089,-0.0161146277666062,0.00759655410968367,-0.0310038738215862,-0.00122538171162618,0.0339505811227827
APOA2,Apolipoprotein A-II,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",33089,-0.010931302490756,0.00754516960207834,-0.0257198349108296,0.00385722992931755,0.147468444923482
APOA2,Apolipoprotein A-II,Eye measures,X5264.Corneal hysteresis (left),33089,0.00964427551817451,0.00760168383460358,-0.00525502479764851,0.0245435758339975,0.204612963197848
APOA2,Apolipoprotein A-II,Eye measures,X5265.Corneal resistance factor (left),33089,0.00370851497351403,0.00757117071424355,-0.0111309796264033,0.0185480095734314,0.624284826321553
APOA2,Apolipoprotein A-II,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,33882,-0.368675425377962,0.265141409983128,-0.888352588944892,0.151001738188968,0.164439932907307
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",49069,0.0474539776875321,0.0199684634150405,0.00831578939405263,0.0865921659810116,0.0174894560279461
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",49069,0.0463272427545978,0.0228905666530416,0.00146173211463624,0.0911927533945594,0.0429977909084537
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",49069,-0.058239376281543,0.0574105655318033,-0.170764084723877,0.0542853321607914,0.31038647977669
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",49069,0.0111081138181647,0.00906599444753926,-0.00666123529901222,0.0288774629353417,0.220494967985407
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",49069,-0.0224408378443121,0.00841251545057325,-0.0389293681274356,-0.00595230756118851,0.00764657813382959
APOA2,Apolipoprotein A-II,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37569,-0.0229165071451046,0.0111150197329185,-0.0447019458216247,-0.00113106846858439,0.0392593019760682
APOA2,Apolipoprotein A-II,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37569,0.0577003232774448,0.0340917075295118,-0.0091194234803984,0.124520070035288,0.0905848071420193
APOA2,Apolipoprotein A-II,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37569,-0.01589819248379,0.0214164729284771,-0.0578744794236052,0.0260780944560252,0.457903970845329
APOA2,Apolipoprotein A-II,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37569,-0.0105232273414988,0.0129292942479242,-0.0358646440674302,0.0148181893844326,0.415720535485828
APOA2,Apolipoprotein A-II,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,49127,0.000199600784405019,0.0191122263770793,-0.0372603629146704,0.0376595644834804,0.991667451694948
APOA2,Apolipoprotein A-II,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,49127,0.000199600784405019,0.0191122263770793,-0.0372603629146704,0.0376595644834804,0.991667451694948
APOA2,Apolipoprotein A-II,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),49127,-0.0078643301714121,0.0138974187575134,-0.0351032709361384,0.0193746105933142,0.571478665388897
APOA2,Apolipoprotein A-II,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',49127,-0.0369344436359198,0.0245075031575157,-0.0849691498246506,0.011100262552811,0.13180893190469
APOA2,Apolipoprotein A-II,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),49127,0.0590398103684201,0.0588622272429416,-0.0563301550277453,0.174409775764586,0.315864516827092
APOA2,Apolipoprotein A-II,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),49127,0.0428371429754717,0.0401793210393648,-0.0359143262616833,0.121588612212627,0.286368831428809
APOA2,Apolipoprotein A-II,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,49127,0.0509051277549545,0.0614164135082535,-0.0694710427212223,0.171281298231131,0.407197699270417
APOA2,Apolipoprotein A-II,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,49068,0.00396660937608673,0.0124463638007545,-0.0204282636733921,0.0283614824255655,0.749960116132312
APOA2,Apolipoprotein A-II,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,49068,0.0172296603706487,0.0218011253737459,-0.0255005453618933,0.0599598661031907,0.429355556794819
APOA2,Apolipoprotein A-II,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,49068,-0.0114340626775269,0.0112731775909106,-0.0335294907557118,0.010661365400658,0.310465211460705
APOA2,Apolipoprotein A-II,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,49068,0.00364123277172711,0.0166475684353048,-0.0289880013614703,0.0362704669049245,0.82686676450229
APOA2,Apolipoprotein A-II,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,49068,-0.00732868414345038,0.0168855947307418,-0.0404244498157043,0.0257670815288035,0.664278564671918
APOA2,Apolipoprotein A-II,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,49068,0.0214738746212883,0.00959274559446526,0.00267209325613638,0.0402756559864402,0.0251956853756402
APOA2,Apolipoprotein A-II,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,35947,0.0815762082054153,0.0191067387554245,0.0441270002447834,0.119025416166047,1.98377239991557e-05
APOA2,Apolipoprotein A-II,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,35947,0.048439366641935,0.0182938100403269,0.0125834989628944,0.0842952343209757,0.00811771517530395
APOA2,Apolipoprotein A-II,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,35947,0.0997751042585481,0.0263793930206576,0.0480714939380591,0.151478714579037,0.000156611523030094
APOA2,Apolipoprotein A-II,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,35947,-0.026411704170616,0.0195934193435197,-0.0648148060839147,0.0119913977426827,0.177703636980001
APOA2,Apolipoprotein A-II,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,49025,-0.00677826428007104,0.0335022493311165,-0.0724426729690594,0.0588861444089173,0.839666499394107
APOA2,Apolipoprotein A-II,Health and medical history,X6151#2.Fractured bone site(s)_Leg,49025,0.055182592991897,0.0416423557340063,-0.0264364242467554,0.136801610230549,0.185134434506098
APOA2,Apolipoprotein A-II,Health and medical history,X6151#3.Fractured bone site(s)_Hip,49025,-0.0971242250436954,0.0794608757216719,-0.252867541458172,0.0586190913707815,0.221612125856744
APOA2,Apolipoprotein A-II,Health and medical history,X6151#4.Fractured bone site(s)_Spine,49025,0.211449481560906,0.0758067763173872,0.0628681999788269,0.360030763142985,0.0052867485153036
APOA2,Apolipoprotein A-II,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,49025,0.02536426998112,0.0314812132685009,-0.0363389080251417,0.0870674479873817,0.42042785893113
APOA2,Apolipoprotein A-II,Health and medical history,X6151#6.Fractured bone site(s)_Arm,49025,0.00366533302315172,0.0368498999061763,-0.0685604707929538,0.0758911368392572,0.92076880837404
APOA2,Apolipoprotein A-II,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,49025,0.017764245593405,0.0156730133124574,-0.0129548604990114,0.0484833516858215,0.257047504274588
APOA2,Apolipoprotein A-II,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",34752,0.0741026076043913,0.0271345838522101,0.0209188232540595,0.127286391954723,0.00633361661903699
APOA2,Apolipoprotein A-II,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",34752,0.0442412405917589,0.0262859962059819,-0.00727931197196557,0.0957617931554835,0.0924117735172175
APOA2,Apolipoprotein A-II,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",34752,0.134259108301172,0.0378005564616693,0.0601700176362996,0.208348198966043,0.000385504928245132
APOA2,Apolipoprotein A-II,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",34752,0.0369055199355817,0.0136219452502095,0.0102065072451711,0.0636045326259922,0.00676183081648762
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",37460,0.0360407644787084,0.0119037943282712,0.0127093275952969,0.0593722013621199,0.00247155625492318
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",37460,-0.0368554586810127,0.0131287455628859,-0.062587799984269,-0.0111231173777564,0.00500781376584506
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",37460,-0.00732585223085621,0.011654426061384,-0.0301685273111689,0.0155168228494565,0.52963390629849
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",37461,0.0541976670732807,0.0270254914301594,0.00122770387016828,0.107167630276393,0.0449477019431316
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",37461,0.0186359805125358,0.0161558126413469,-0.0130294122645041,0.0503013732895758,0.248729966623175
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",37461,0.0305913048860302,0.0294848082866672,-0.0271989193558376,0.0883815291278979,0.299518311304348
APOA2,Apolipoprotein A-II,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,49068,0.016180764419407,0.024474583838012,-0.0317894199030966,0.0641509487419105,0.508539459596408
APOA2,Apolipoprotein A-II,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,49068,0.0262605197993272,0.019662346855792,-0.0122776800380251,0.0647987196366795,0.181703394915554
APOA2,Apolipoprotein A-II,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,49068,-0.0290195445375874,0.040902079575772,-0.109187620506101,0.0511485314309258,0.478029627181684
APOA2,Apolipoprotein A-II,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,49068,0.0215210579476653,0.022061781015886,-0.0217200328434713,0.064762148738802,0.329328536901689
APOA2,Apolipoprotein A-II,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,49068,-0.00598820380912534,0.0225839078962109,-0.0502526632856987,0.038276255667448,0.790893830787248
APOA2,Apolipoprotein A-II,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),49068,0.0675202462406831,0.0275254908031003,0.0135702842666065,0.12147020821476,0.0141750040485897
APOA2,Apolipoprotein A-II,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,49068,-0.00669589886287728,0.00795120866932286,-0.0222802678547501,0.00888847012899553,0.399728724939038
APOA2,Apolipoprotein A-II,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,33483,0.103978126603552,0.0201506385691603,0.0644828750079981,0.143473378199106,2.56674763040598e-07
APOA2,Apolipoprotein A-II,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,33483,0.0894109577755627,0.0243446017985914,0.0416955382503236,0.137126377300802,0.000242548892217416
APOA2,Apolipoprotein A-II,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,33483,-0.0542315561227279,0.0181051426509738,-0.0897176357186365,-0.0187454765268193,0.00275490670442279
APOA2,Apolipoprotein A-II,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,33483,-0.0244363451707986,0.0162449725958232,-0.0562764914586121,0.00740380111701499,0.132584135249759
APOA2,Apolipoprotein A-II,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,49156,-0.0202300184566755,0.00965617739634815,-0.0391561261535178,-0.00130391075983311,0.0361801899853603
APOA2,Apolipoprotein A-II,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,49156,0.0539857954102059,0.0317235777932389,-0.00819241706454234,0.116164007884954,0.0888162007924735
APOA2,Apolipoprotein A-II,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,49156,-0.00971912099780683,0.0085050150545305,-0.0263889505046866,0.00695070850907294,0.253154978420118
APOA2,Apolipoprotein A-II,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,49156,0.0267741469954078,0.00795679171369426,0.0111788352365671,0.0423694587542486,0.000766996052148488
APOA2,Apolipoprotein A-II,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,49156,0.00228225388102037,0.0135497088502634,-0.0242751754654958,0.0288396832275365,0.866242229155285
APOA2,Apolipoprotein A-II,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,49156,0.0148094573284564,0.0121018839471739,-0.00891023520800449,0.0385291498649173,0.221067536164639
APOA2,Apolipoprotein A-II,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,49156,0.0129423810528757,0.00859201412079002,-0.00389796662387276,0.0297827287296241,0.131998670126024
APOA2,Apolipoprotein A-II,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,49156,0.035721919211731,0.0280157320726205,-0.0191889156506051,0.0906327540740672,0.202300144497458
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,42898,0.00838471083896953,0.00883920134251182,-0.00894012379235365,0.0257095454702927,0.342849077107248
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,42898,0.0345260783902289,0.00869938268597997,0.0174752883257082,0.0515768684547497,7.25895170746765e-05
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,42898,-0.0386601157001888,0.0112395783602623,-0.0606896892863028,-0.0166305421140747,0.000584148217599706
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,42899,-0.0270760800112047,0.0174363368940923,-0.0612513003236256,0.0070991403012161,0.120480224909622
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,42899,-0.0164384779030901,0.00995323482131284,-0.0359468181528632,0.0030698623466831,0.0986439139349088
APOA2,Apolipoprotein A-II,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,48969,-0.0318335683540071,0.00913604206554034,-0.0497402108024662,-0.0139269259055481,0.000494289663306534
APOA2,Apolipoprotein A-II,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,48969,-0.00854330828344498,0.00718394424360855,-0.0226238390009177,0.00553722243402779,0.234365977332428
APOA2,Apolipoprotein A-II,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,48969,0.0082429148329617,0.00811699627048103,-0.00766639785718111,0.0241522275231045,0.309873438412186
APOA2,Apolipoprotein A-II,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,48969,0.0373734394931596,0.0123903272955684,0.0130883979938455,0.0616584809924736,0.0025616180609639
APOA2,Apolipoprotein A-II,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),48988,-0.0115833224893518,0.00772128400091952,-0.0267170391311541,0.00355039415245042,0.133583043889
APOA2,Apolipoprotein A-II,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,48988,0.0402193874255586,0.0107988880673233,0.0190535668136049,0.0613852080375123,0.000196307162737051
APOA2,Apolipoprotein A-II,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),49068,-0.00951600089542424,0.0078995124834261,-0.0249990453629394,0.00596704357209091,0.228359552485486
APOA2,Apolipoprotein A-II,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,49068,-0.0113461136570909,0.00991250678653309,-0.0307746269586957,0.008082399644514,0.252377474105395
APOA2,Apolipoprotein A-II,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,49068,0.0440386112269083,0.0208036784157804,0.0032634015319787,0.0848138209218379,0.0342832057014378
APOA2,Apolipoprotein A-II,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,49068,-0.0148878574355702,0.0194435628933623,-0.0529972407065603,0.0232215258354199,0.443866064491803
APOA2,Apolipoprotein A-II,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,49068,0.0424066747880731,0.0235803211319751,-0.00381075463059821,0.0886241042067444,0.0721295448874295
APOA2,Apolipoprotein A-II,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,49068,-0.000234961633099213,0.0239211185783192,-0.0471203540466048,0.0466504307804064,0.992163119193902
APOA2,Apolipoprotein A-II,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",40136,-0.0078822315185917,0.00475518393867355,-0.0172023920383919,0.00143792900120846,0.0974237796985285
APOA2,Apolipoprotein A-II,Physical activities,X864.Number of days or week walked 10+ minutes,48746,0.0560128866299319,0.0257231068405362,0.00559559722248092,0.106430176037383,0.0294524683542273
APOA2,Apolipoprotein A-II,Physical activities,X874.Duration of walks,46443,0.00451190118179876,0.00368029056879748,-0.00270146833304429,0.0117252706966418,0.220228664724536
APOA2,Apolipoprotein A-II,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,48215,0.0460984546906072,0.0249889787770417,-0.00287994371239445,0.0950768530936089,0.0650887749055855
APOA2,Apolipoprotein A-II,Physical activities,X894.Duration of moderate activity,44041,0.0354870015944724,0.030035563314833,-0.0233827025026003,0.094356705691545,0.237422568480121
APOA2,Apolipoprotein A-II,Physical activities,X90087.No-wear time bias adjusted average acceleration,32622,0.00551932756206869,0.00822938476590873,-0.0106102665791124,0.0216489217032498,0.502459526122127
APOA2,Apolipoprotein A-II,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,48148,0.103992804583243,0.025563871580905,0.0538876162846689,0.154097992881816,4.7612626925763e-05
APOA2,Apolipoprotein A-II,Physical activities,X914.Duration of vigorous activity,40296,0.0144816714336957,0.00432020080139402,0.00601407786296344,0.022949265004428,0.000804602371021452
